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OPTIMIZATION AND CHARACTERIZATION OF LAB-ON-A-CHIP ELEMENTS: 
MICROFLUIDIC CHAMBERS AND MICRONEEDLES 
Puneet Khanna 
ABSTRACT 
 
In this work, MEMS based fabrication is used to engineer multifaceted 
enhancements to microfluidic systems such as lab-on-a-chip devices. Two specific 
elements of microfluidic systems are the focus of this study: microfluidic chambers and 
microneedles. Microfluidic chambers, which are back-end passive elements, via 
proposed material and structural modifications, are shown to exhibit reduced non-
specific DNA binding and enable increased cell lysis efficiency. Microneedles, which are 
front-end interfacing elements, have been fabricated in silicon and in silicon dioxide 
varieties. The geometry of silicon microneedles has been varied via DRIE processing to 
yield sharpened tips. Sharpening of microneedle tips provides reduced skin insertion 
force without compromising structural strength. Variation of skin insertion force of 
microneedles with change in tip sharpness has been studied, and toughness of human 
skin derived to be approximately 26 kJ/m2. The axial and shear fracture limits of the 
microneedles have also been studied. Axial fracture of 36 gauge silicon needles takes 
place at an average force of 740gf. Shear fracture force of silicon needles varies from 
275gf (33 gauge needles) to 35.6gf (36 gauge needles). Fracture limits of circular and 
square shaped silicon dioxide needles show reduced strength of square needles; which 
is pronounced in the case of shear fracture.  
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CHAPTER 1 
INTRODUCTION 
 
Recent advances in genetic and tissue engineering, molecular biology, 
biochemistry, embryology and cell biology have triggered a need for increased 
customization of ancillary technologies. Specifically, Bio-MEMS/micromachining 
technology is playing a proactive role in assisting explorations into uncharted research 
territory, and at the same time enabling the surge to miniaturize and mobilize established 
protocols. In this work, MEMS based fabrication is used to engineer multifaceted 
enhancements to microfluidic systems such as ‘Lab-on-a-chip’ (LOC) devices. 
 
1.1 Lab-on-a-Chip Devices 
A lab-on-a-chip (LOC) is a device that integrates one or several laboratory 
functions on a single chip that may be millimeters to a few square centimeters in size. 
These devices are capable of handling extremely small fluid volumes - down to less than 
picoliters. Lab-on-a-chip devices are a subset of Micro-Electro-Mechanical Systems 
(MEMS) devices and often also called "Micro Total Analysis Systems" (!TAS). However, 
the term ‘Lab-on-a-chip’ is more generic as these microfluidic systems are capable of 
performing much more than just analytical functions. 
The first LOC analysis system was a gas chromatograph, developed in 1975 [1]. 
During the next two decades, LOC research started to gain ground as scientists 
developed concepts for microfluidic systems [2, 3]. Specific functional elements such as 
flow sensors [4, 5], micro-pumps [6, 7] and micro-valves [8, 9] were developed. 
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Researchers started to construct highly integrated compact devices. Systems 
demonstrated the inclusion of pre-treatment steps, usually done at lab-scale, thus 
elevating their utility from simple sensory functions to complete laboratory analysis. 
These devices have a wide range of applications. Chemists are using such tools 
to synthesize new molecules and materials (rapid screening [10, 11], microreactors for 
pharmaceutics [12]), and biologists are using them to study complex cellular processes 
(e.g. biochemical analysis [13, 14], environmental monitoring [15, 16], medical 
diagnostics [17, 18], cellomics [19, 20]). LOC devices are slowly becoming enabling 
devices for research in fields such as genomics [21], proteomics [22], 
pharmacogenomics [23] etc.  These systems can offer point-of-care diagnostic abilities 
[24, 25] that could revolutionize medicine. 
The ability to perform laboratory operations on a small scale using miniaturized 
devices is highly attractive [26]. Small volumes reduce the time taken to synthesize or 
analyze a product. The unique behavior of liquids at the microscale allows greater 
control of molecular concentrations and interactions. Reagent costs and the amount of 
chemical waste can be much reduced. The compact size of units is a benefit in itself; 
increasing deployment possibilities.  Samples can be analyzed at the point of need 
rather than a centralized laboratory. Massive parallelization due to compactness, allows 
high-throughput analysis. Also they offer a safer platform for chemical, radioactive or 
biological studies because of integration of functionality and smaller fluid volumes/stored 
energies. Furthermore, benefits typical to MEMS systems also apply to these devices, 
i.e. they have low fabrication and disposal costs, and are conducive to mass production.  
 
1.2 Elements of Lab-on-a-Chip System 
 A typical LOC system contains multiple elements, active or passive. The 
incorporation of most elements is application dependent, though some passive elements 
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are almost always required. Active elements may be micropumps [6, 7], microvalves [8, 
9], heaters [27, 28], micro-sonicators [29], flow sensors [13, 14] among various others. 
Passive elements may be microfluidic chambers [30-32], microfluidic channels [33, 34] 
or other external interface elements.  
 
Figure 1: Sketch of a prototypical LOC system [35] 
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Figure 1 shows a sketch of a typical LOC system. The system depicted consists 
of multi-level functional layers integrated together. The development of such a system is 
usually highly complex. There are numerous parametric dependencies at each design 
level. An efficient system level layout and effective integration protocol is crucial, and so 
is design optimization of each constituent element. Every element of the system needs 
to be design as per the specific application requirements. Enhancement of any particular 
element can lead to profound gains in various output specifications.  
 
1.3 Systems for Biofluid Transport and Manipulation 
In this research, LOC systems that specifically transport analytes through skin 
and manipulate biofluids have been investigated. Examples of such systems include 
LOC’s for heath monitoring or disease detection via biomarker analysis [36, 37], DNA 
extraction [38, 39] etc. Different LOC systems might need to interact with skin directly to 
perform varying tasks, such as, extract analytes, deliver therapeutic entities or extract 
physiological signals. For example, an LOC might be a system for medical diagnosis; 
analyzing biological entities, such as blood [40-42], extracted through skin. Other 
possible applications may be recording and analysis of bioimpedance [43-45], or drug 
delivery [46, 47]. Such devices would employ an external biotic interface. The specific 
type and design of the interface would application dependant. They may be active 
elements (microelectrodes for electroporation) or passive elements (microneedles for 
biofluid extraction). Such systems promise to bridge the biotic (organism/skin) and 
abiotic (environment) realms in unanticipated ways.  
Currently accepted approaches to collect samples through skin include disruption 
in skin structure through needle puncture, removal of the stratum corneum through gels 
[48] or tapes [49, 50], or laser ablation followed by vacuum assisted extraction [51].  
Micromachined electrodes and needles (microelectrodes or microneedles) can enable 
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collection of the same information, with significantly less trauma to the tissue, and have 
the potential of even eliminating it [52, 53].  
The microneedles, when incorporated into the LOC, will enable the development 
of a generic front end to the micro-system. Such an interface can take care of most 
applications involving skin interaction, whether diagnostic or therapeutic in nature. The 
LOC sub-systems can be broadly classified by the type of entity transferred: physical 
(fluid transfer) or electrical (charge transfer), and the system may incorporate any or 
both types of interactions.   
The LOC system may be either a stand-alone diagnostic or therapeutic system, 
or have both capabilities. An active feedback controlled system in which the therapy 
depends upon the diagnosis constitutes a ‘smart’ system. The data collected may either 
be used locally or be relayed further; in which case the system would incorporate an on-
board data communication capability; to transmit raw or significant data. Advanced 
sensor systems would follow a node-based approach for a global level monitoring. They 
shall include low power wireless communication protocols within multiple nodes, 
distributed computing algorithms and protocols at these nodes. 
 The MEMS devices that interact with the skin would depend upon the application 
and will generally be microfluidics based (for fluid transfer systems), or IC based (for 
charge transfer systems). Fluid transfer systems can be expected to be more complex 
and will have multiple component levels. 
 
1.4 Lab-on-a-Chip Elements Under Investigation 
This research aims to enhance the state of the art of LOC systems via 
optimization and characterization of specific constituent elements. The first element is 
the microfluidic chamber, which forms the most prevalent back-end element of a LOC 
system. There are multiple design considerations that go into optimizing the microfluidic 
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chamber, such as material, functional and architectural. Common variables might be: 
compatibility of building material with the application; deployment scenarios; number of 
chambers required for desired reliability; type of fluid being handled (blood, ISF, 
suspension of cells, specific chemical); etc. 
The second specific element that has been studied is a typical external interface 
– microneedles.  As the term implies, these are similar to regular hypodermic needles, 
except that they are much smaller. In the case of microneedle design all the material, 
functional and architectural considerations that were there for microfluidic chambers still 
apply. But there get added many more parametric interdependencies; the geometry of 
the individual needle, the structural strength of the needles, biocompatibility, toughness 
of the biotic layer being punctured, etc. 
 
1.5 Manipulation of Biofluids in Lab-on-a-Chip Systems 
 Most LOC systems need to handle biofluids within microfluidic chambers. 
Typically these chambers have no functionality other than being passive containers. 
However, even this task needs careful design of the element. Material, functional and 
architectural considerations exist. A major issue while handling biological fluidics is 
biocompatibility.  
‘Biocompatibility’ requirements vary as per specific applications. Generally, the 
microfluidic chamber material should act as an appropriate host to the biological entities 
for the application. There should not be any toxic or detrimental effects on the biofluids, 
that might affect system efficiency. Continuous research is required to gain insight into 
how biomaterials interact with the chamber body and eventually how those interactions 
determine the success of the LOC device. 
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1.6 Interfacing Lab-on-a-chip Systems With Skin 
The iterative development of noninvasive, bio-engineered lab-on-a-chip systems 
should not ignore the body’s own exquisite material solution to biotic/abiotic interface 
design. Seamless coupling to the body surface requires a better understanding of the 
molecular architecture of the SC as a polymer film and the functional unit organization of 
the epidermis.  This challenge amounts to nothing less than a beginning understanding 
of the boundary conditions of the human body.  This will necessitate integration of broad 
advances in a wide variety of fields viz. microsystems, clinical medicine, cell and 
molecular biology, and information technology.  Such extended interface systems would 
be typically freestanding, multifunctional, multimode, microfluidics-based sensor systems 
coupled to human skin for real time monitoring at global (physiological) and local 
(molecular) levels. 
 
Figure 2: Bioengineered interface between analogous biological and LOC systems [35] 
 
The scope of systems containing bio-engineered micro-interfaces goes beyond 
sampling and extraction of high-quality distributed physiological data. Advanced systems 
hold the potential to incorporate both diagnostic as well as therapeutic functionality. 
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Such systems would utilize information in the same manner as the body uses the skin 
surface for sensorimotor feedback control [54-60].   
Development of bio-engineered skin-interfacing LOC systems require 
interdisciplinary research combining such diverse fields as tissue engineering, molecular 
biology, anatomy, physiology, medical physics, biology, mechanical engineering, 
microfluidics, chemical processes, microfabrication, nanotechnology, and signal 
processing.  
When a foreign object is introduced in the body, the body rejects it by forming 
scar tissue around it, thus isolating it from the rest of the body.  An interface between the 
sensing system and the skin needs to ‘ensure that the body does not initiate this defense 
mechanism. Such ability would make it possible for the interface material to act as a 
seamless bridge that performs transfer of signals and samples to the sensing system. 
Systems with such interfaces would have the potential to integrate detection, 
diagnostics, and treatment of adverse medical and physiological states affecting the 
human body.  An example of major drivers for such systems is diabetes.  There are 
numerous active efforts underway to develop a seamless glucose sensing and insulin 
delivery systems that can function over extended durations. Other systems could enable 
diagnosis of adverse states like heat prostration, exhaustion, dehydration, hemorrhagic 
shock, and anxiety.  This approach can potentially result in physiologically and clinically 
relevant information far in advance of changes in central measures like blood pressure, 
arterial blood gases or acid-base status. 
Positioning sensors strategically on the body surface and incorporating 
developments in Computer Science and Engineering viz distributed computing 
algorithms, and low power wireless communication, can allow observation of the target 
biological processes in the body in real time, similar to electrocardiography and 
electroencephalography. Essentially, the bio-engineered interfaces will facilitate (a) 
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characterization of the quantitative boundary conditions of the human body; (b) 
determination of variation of those conditions with disease and environmental change, 
and; (c) putting into effect suitable therapeutic response, as needed. 
  
1.7 Anatomy of Skin 
The research entails focus on the unique biological boundary of the body 
manifested by the surface of the human skin.  Specifically, attention is drawn to the 
outermost layer of the skin, the stratum corneum (SC), which, as the terminally 
differentiated (dead) product of epidermal differentiation forms the ultimate biopolymeric 
interface with the environment.  The SC, viewed through the lens of a materials 
engineer, is a multifunctional nanocomposite with all the hallmarks of a smart material.  
The strategic location of this highly organized, thin (~20 µ), bioengineered film place it in 
an optimal location to mediate biotic/abiotic interactions.  Improved sensor systems for 
noninvasive detection of physiologically relevant mechanical, electrical, or magnetic 
signatures at the surface of the body (data beyond current electrocardiography or 
electroencephalography) require bridging to the body via this complex but assessable 
biological structure.   
To develop a long lasting interface, the nuances involved in interfacing with skin, 
need to be understood. Towards that goal, a brief review of the skin is provided 
hereunder. 
1.7.1 General Structure 
Skin is the largest organ of the human body and accounts for approximately 16% 
of the body weight. It serves multiple purposes which can be broadly classified into four 
functions – 1) Protection: physical, biological, against UV light, from dehydration; 2) 
Thermoregulation: control of body temperature 3) Metabolic functions: synthesis of 
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vitamin D, excretion of waste products, storage of fat; 4) Sensory functions: pressure, 
heat, cold, contact, pain, as well as integral interaction with vision (pigmentation 
patterns) and smell (pheromone release). It is evident from its range of functionality that 
the skin hosts complex physiological, biomechanical and biochemical processes, all 
occurring simultaneously. 
 
Figure 3: Cross-section of skin [61] 
  
The skin possesses a layered structure comprising of various kinds of tissues. It 
has two layers, the dermis and the epidermis. The epidermis is the outer layer of the 
skin. Being a tough and waterproof layer, it protects the inner regions. The underlying 
dermis is a thicker layer and is responsible for imparting strength and elasticity to the 
skin. Beneath the dermis is the subcutaneous layer, which is not part of the skin itself. It 
is a layer of tissue made of protein fibers and adipose tissue (fat). It contains glands, 
sensory receptors and other skin structures.  
 The protection provided by the epidermis forms the first barrier against harmful 
foreign substances. Most of the cells (approximately 90%) in the epidermis are 
“keratinocytes”. They produce a tough, fibrous, intracellular protein called keratin; hence 
the name. The keratinocytes are stacked in layers. The youngest cells occupy the lower 
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layers while older cells are present in the upper ones. The lower layer cells multiply 
continually, while the older upper layer keratinocytes constantly slough off. By the time 
the cells move up to the uppermost layer of the epidermis, they are dead and completely 
filled with the keratin. From bottom to top the layers are named stratum basale, stratum 
spinosum, stratum granulosum, and stratum corneum. 
 
 
Figure 4: Cross-section of epidermis [62] 
 
Various skin properties are routinely measured at the broadest classification level 
whereby considering the entire epidermis as a single functional entity. Such information, 
though essential, is incomprehensive in that it does not account for the heterogeneity of 
the epidermis. It is imperative to possess precise knowledge of the distinct properties of 
each cutaneous component to design interfaces that interact individually with the cuticle 
layers. The stratum corneum in particular dominates various design considerations and 
is often times the principal cause for development of micromachined interfaces.  
1.7.2 Stratum Corneum 
The outermost layer of the epidermis, the stratum corneum (SC), is a thin, 
flexible, high impedance biopolymer composed of interconnected ‘dead’ cells called 
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corneocytes.  This complexly organized, anucleate, 15-20 µm thick, biopolymeric 
structure is essential to life and serves to couple the organism to the environment.  This 
structure is particularly well developed in humans who lack a protective mantle of fur. It 
is the major barrier to all environmental insults (climatic, toxic from xenobiotics or 
microbial) [63]. Despite its resilience it can bind a certain amount of water to stay soft, 
smooth and pliable even in a dry environment, thus allowing free body movement 
without cracking or scaling of the skin surface.   
The underlying hypothesis in the development of bio-engineered systems is that 
the stratum corneum can be a portal to the biological and physiological processes. It 
plays a major role in modulating sensory signals for visual and tactile perception. Also, 
the hydration status of the stratum corneum is a key determinant of the mechanical, 
electrical, optical, and chemical properties of the skin. The properties of this layer serve 
as a health status indicator and valuable insights into the human biosystem can be 
attained by characterizing the quantitative boundary conditions of the human body and 
determining variation of those conditions with disease and environmental change.  
As a secondary consideration, the condition of this layer serves vital social and 
cultural functions as it is a major determinant of our appearance and is thus of central 
interest to the cosmetic industry. The multifaceted significance of the stratum corneum 
necessitates a multidisciplinary approach towards its analyses. Current researchers 
include dermatologists, cosmetic scientists, physiologists, neonatologists, 
pharmaceutical scientists and bioengineers.  
 
1.8 Designing a Lab-on-a-Chip System 
 Despite architectural differences, the tasks involved in designing the LOC 
systems have certain standard objectives. These objectives establish the foundation of 
knowledge and capabilities required to build the specific system. They include: (a) 
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understanding the cellular and molecular biology of the biofluid being handled; and (b) 
developing tools, techniques and protocols to non-intrusively or semi-intrusively collect 
relevant physiological information using an array of micro/nano probes, sensors and 
analysis protocols. For a global level system it includes: (c) using distributed computing, 
imaging and wireless communication to analyze, correlate and understand the response 
of the skin at various body sites to a single controlled stimulus and across a group of 
sensors at a population level. Fluid transfer systems entail: (d) developing models to 
understand microfluidic coupling between the stratum corneum and MEMS-based tools 
and on-chip immunoassays and sensors. Therapeutic systems include: (e) developing 
therapeutic application methodologies and protocols to deliver required medication 
based upon computational algorithms. 
Each of the objectives mentioned above encompasses numerous tasks, which 
involve of varied undertakings in biology, medicine, chemistry, information technology 
and microtechnology. The first task includes interface testing on various microfluidic 
chamber surfaces. Relevant target measurements on skin such as bio-impedance, 
immunoassay and analyte detection would have to be conducted. This would assist in 
identifying key analytes to be monitored, and determining the baseline and deviation 
standards. Information/models and images would be used to enable extrapolation of 
data from the tissue level microenvironment, to an understanding of meaningful 
physiological responses at the level of the organism. For reagent analysis systems, 
immunoassays and analyte detection protocols have to be developed. Sensor/analyzer 
designs have to be built accordingly by the MEMS designers.  Deciding upon the 
physical design and establishing fabrication procedures of the individual LOC elements 
would form the most vital component of system development. The biggest challenge 
would lie in integration of the various microdevices (such as the passive microfluidic 
components, sensors, active elements etc.). To ease the development process, the LOC 
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systems can be expected to have a modular design, i.e. each sub-system would be 
functionally independent.  However sub-system development cannot be independent of 
other tasks and continuous collaboration between MEMS and biotechnology/information 
technology groups would have to be a standard feature of the design process.  
If an LOC is expected to be autonomous, the information technology tasks could 
include development of data processing capability and a data transfer interface. 
Depending upon whether the LOC unit is a stand-alone node or part of a global sensing 
system, the tasks would include creation of low power wireless communication protocols 
within multiple nodes, distributed computing algorithms and protocols at these nodes, 
and transmission of raw or significant data collected from individual nodes.  Data 
management tasks would comprise of signal conditioning, post processing, sensor 
fusion, and feedback control to manage and optimize the device/skin interface. Data 
depiction front-ends would have to be created to facilitate easier data interpretation, e.g. 
providing the data as a 3-D image composite.  
 
1.9 Designing the Lab-on-a-Chip Elements 
Element design is a critical part of designing an LOC system. It involves 
simultaneous consideration of multiple parameters. There is always present some form 
of trade-off. In case of microfluidic chambers, an example would be non-specific DNA 
binding vs. ease of fabrication, life span vs. ease of integration etc. For microneedles, 
such considerations would be ease of skin penetration vs. ease of fluid flow, probe 
strength vs. biocompatibility etc. There is no specific optimum design; it varies with each 
application. The combinatorial possibilities are vast and the parametric interdependency 
highly complex. Every application will have a few structural or functional demands that 
bear higher priority than others. Fortunately, not every application needs a new needle 
design. Most applications can be grouped into classes having broadly similar 
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requirements. Thus generic element arrays can be designed with specifications that 
provide enough latitude for parametric variations within the class.  
1.9.1 Functional Requirements of Microfluidic Chambers 
Interface elements in LOC devices have to satisfy diverse functional requirements. 
Microfluidic chambers don’t have to usually satisfy strict mechanical requirements. Their 
most significant requirement is biocompatibility with the biofluids. Non-specific binding is 
an inherent problem. Biological entities adhere to surfaces that they are not supposed to, 
and detach when not supposed to. Thus non-specific binding may interfere with the 
obtained output, and reduces the overall sensitivity. Efficient cleaning of the microfludic 
chamber suddenly becomes a top priority is many times not a trivial task.  
1.9.2 Functional Requirements of Microneedles 
In the case of microneedles, a large majority of requirements are mechanical in 
nature. Bioengineered interfacing entails insertion of microneedles into the upper 
epidermal layers of the skin, and thus the probes have to be able to withstand the 
applied pressure and puncture the skin without fracture. Optimum design demands 
characterization of various mechanical features such as mechanical strength, buckling 
characteristics, fracture point, elasticity, angular strength, ease of penetration etc. 
Microneedles have to be further characterized for their capability to withstand fluidic 
pressure at the sidewalls and the inlet pressure for a particular flow rate. 
. This requirement is imposed on the needles too, with regards to their interaction 
with skin. Interaction of non-biocompatible needles with cells and tissue is known to 
trigger “foreign body response” and cause bio-fouling. Biologically, such a system 
constitutes a breach in the integrity of the organism and would be responded to as a 
wound. Thus it becomes difficult to determine whether one is sampling "intracellular" 
fluid from impaled cells or "extracellular" fluid from needles placed between cells.  The 
16 
most common approach to minimize biofouling is surface passivation of the functional 
materials.  
Microfluidic properties of microneedles are also important design factors. The 
design has to take into account fluid flow characteristics for the passing fluid and also 
environmental flow resistance. There should be no clogging of the fluid at orifices or 
along the needle lumens. Also capillary forces have to be sufficient to ensure fluid 
delivery or extraction. 
 Other common parameters affecting microneedle design include adhesive 
interactions (adhesion of analytes to the needle), life duration, chemical inertness and 
biodegradability.  
 
1.10 Design Variables for Lab-on-a-Chip Elements 
Common variables that control the component characteristics can be broadly classified 
into: 1) Material selection 2) Geometric considerations 3) Array layout 
1.10.1 Material Selection 
There is no one best material available for the fabrication of microfluidic 
chambers or needles. The choice varies according to the application.  
In the case of microfluidic chambers, polymers such as polydimethyl siloxane 
(PDMS) [64], polymethyl methacrylate (PMMA) [65] are highly popular due to their ease 
of fabrication. Plastics derivatives like polycarbonate [66] and cyclic olefin copolymers 
[24] are also popular due to the cost benefits. 
Metallic needles [67-69] are popular due to strength and biocompatibility; they 
have lowest probability of causing allergic reactions. However, the minimum size of 
needles possible is relatively large. They are relatively easy to fabricate; common 
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methods being micromolding or electroforming, Stainless steel is used quite often due to 
its high strength, non-corrosive nature and low price.  
Non-metallic materials have other advantages. Glass microneedles [70] provide 
ease of fabrication while silicon dioxide microneedles [71, 72] offer good biocompatibility 
characteristics. Polymer microneedles [73-75] are of interest since they are 
biodegradable. These microneedles can be used without danger of infection due to 
needle tips breaking off. Conductive polymers are often used for microelectrodes due to 
their selective interaction properties with proteins, enzymes and antibodies thus making 
them ideal for certain biochemical sensing applications. Furthermore, polymers are 
highly flexible too. The most common and prevalent material for microneedles is silicon 
due to high strength, design flexibility and ease of fabrication [76-79].  
1.10.2 Geometrical Considerations 
Geometric considerations for microfluidic chambers are dependent upon the fluid 
being handled, its viscosity, Reynolds number and Newtonian characteristics among 
other things. The specific application and the employed protocol determine the size and 
arrangement of the chambers.  
Geometry of the microprobe affects most of the electrical, mechanical or other 
characteristics highlighted earlier. Common geometrical considerations are needle 
length, width, area/perimeter of cross-section, shape, thickness of sidewalls, tip 
geometry, taper angle, etc. 
Each geometrical variable can affect a number of parameters and thus the 
optimum choice of geometry is often a trade-off between efficiencies. For example, 
sharper needle tips can be expected to require less force for insertion, but the reduced 
penetration force comes at the expense of reduced strength near the tip [80].   
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Needle length determination is particularly critical as the needles must be 
sufficiently deep to allow reliable test results, and for drug delivery or sample extraction, 
they have to reach the blood capillaries. The possibility of fracture and buckling increase 
as probe length increases.  Also, in order to be painless, the needles cannot be so long 
as to touch the nerve endings. Increasing cross-sectional area increases strength but 
may compromise certain insertion force into skin. Constriction of needle lumen size is 
limited by the size of species being transferred. Finally, biofouling properties always 
impose critical constraints, it being less intensive for less invasive geometries.  
 Microneedle are most often used in an array formation. Thus device functionality 
depends upon the not only on their individual, but also on their ‘team’ efficiency. Array 
size, density and configuration are most important considerations. A very closely packed 
array can cause unsuccessful penetration due to ‘bed of nails’ effect [81]. 
 
1.11 Technological Merit of Skin Interface Elements 
Micromachined needles form the technological foundation for bio-engineered 
skin interfaces for the LOC devices. The physical characteristics of microneedles provide 
unique technological advantages to these systems as compared to traditional invasive 
methodologies. Next generation therapeutic methods using advances in genomics, 
proteomics, pharmacogenomics etc., have all come into existence due to the capabilities 
provided by these micro-components. 
Tissue interaction is usually done using macroscale components such as 
hypodermic needles (henceforth referred to as macroneedles). Such components offer 
immense utilitarian advantages in their being easy to fabricate and handle. They are 
irreplaceable in appropriate problem identification and drug delivery applications that 
warrant the use of large sized interface tools. However with the advent new technologies 
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and discoveries, these conventional tools are being fast replaced with their 
micromachined counterparts.  
1.11.1 Benefits From Microneedles 
In typical clinical and biomedical applications, drug injection or biofluid sampling 
is done using hypodermic needles. Though utilitarian, this method causes undesirable 
pain and excessive tissue trauma. This is particularly troublesome when frequent 
administration of drugs is necessary (such as administration of insulin). Furthermore, 
control of drug delivery is highly approximate using macroneedles.  
A painless alternative to macroneedles, which has lately started to become 
popular, is the transdermal patch. It is simply a piece of plastic with an adhesive on it 
with the drug being suspended in the adhesive. The patch is stuck on the skin and the 
drug passively diffuses slowly to lower layers. However, this method of drug delivery 
poses certain challenges. The effectiveness of the adhesive is directly affected by the 
concentration of the drug within the adhesive. Thus, if a larger dose of the drug is 
required, either it has to be reapplied more frequently or a larger patch has to be used. 
Increasing the concentration of the drug does not help if the adhesive bond with the skin 
is weak [82]. Furthermore, it is a slow method and not very precise, and is thus not 
suitable to many applications. The barrier properties of the stratum corneum pose 
unique obstacles to drug application by providing for a very low topical bioavailability 
[83]. The “route” taken by the externally applied drug is tortuous – around the dead, 
dense corneocytes. The permeant diffuses in the intercellular channels, which contain 
structured lipid bilayers. Thus the problem is compounded, as molecules have to cross, 
sequentially, lipophilic and hydrophilic domains.  
Microneedles are increasingly being sought out as an alternative to the 
macroneedle and the transdermal patch as it combines their advantages while 
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eliminating the disadvantages of both. In recent times, numerous types of micro needles 
have been fabricated and used for transdermal drug delivery [84-88], vaccine delivery 
[89], fluid analysis and sampling [90], dialysis [91] and cellular DNA delivery [92] among 
other applications.  
Vital technological advantages obtained by using microneedles are: 
1.11.1.1 Increased Permeability 
The self-sealing properties of the stratum corneum are poorly understood.  It is probable 
that the stratum corneum seals holes spontaneously up to a given magnitude, but 
beyond that limit it cannot close itself. This property can be used by microneedles to 
increase the permeability of skin by orders of magnitude, making it is possible to diffuse 
macromolecules across the skin. Thus in some cases, the microneedles may not 
themselves deliver the drug. Unmedicated microneedles may simply puncture the skin 
and then medicines may be smeared on and left to be rapidly absorbed through the 
holes.  
1.11.1.2 Application Customization 
Microneedles can be fabricated in various shapes (cylindrical, pyramidal, polyhedral, 
etc.) or sizes and may be hollow or solid. Such geometrical flexibility allows for 
fabrication of microneedle arrays customized for the type and volume of drug and the 
duration of use. This feature also translates to flexibility in method of drug delivery. For 
example, medicines may be delivered the way a regular hypodermic needle does so, or 
microneedles may be coated with medication which would be absorbed on contact.  
1.11.1.3 Material Flexibility 
Microneedles can be fabricated using a variety of materials such as silicon, glass, 
carbon nanotubes, biodegradable polymers, and metals. The choice of material would 
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depend on the application. For example, metallic microneedles are the most popular 
because they have high strength and biocompatibility. Polymer needles have the 
advantage of being biodegradable and thus if the tips snap off during insertion, the body 
would simply absorb the remains. 
1.11.1.4 Minimal Medical Training Requirements 
Microneedles are expected to become a boon for immunization programs in developing 
countries as they could be applied by people with minimal medical training. Drugs could 
similarly be administered at home instead of presently compulsory clinical visits. The 
significance of such capability is further enhanced due to possibility of mass vaccination 
or antidote administration in bioterrorism incidents. The cause is further helped by the 
fact that microneedle fabrication promises to be less expensive than any other reported 
technology. 
1.11.1.5 Site Specific Therapy 
Highly targeted drug administration to individual cells is possible using microneedles. A 
potential application is to modulate the immune system by administering drugs precisely 
into the area where special immune cells reside.  Langerhans cells, for example, are the 
major immunomodulatory cells which modify delivery of HIV particles from the epidermis 
to the lymph nodes - these cells are located only 40-50 microns deep in the epidermis.  
Vaccine delivery directly to these cells provides a target of mass vaccination strategies.  
1.11.1.6 Precise Control of Drug Quantities 
The small volumes of drug passing through the microneedles, either through diffusion or 
through auxiliary pumping systems make the delivery process highly controllable.  
Microneedles are presently at various stages of development though they are yet 
to be introduced clinically. They will surely revolutionize drug delivery systems and 
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provide more options and possibilities to patients. The day is not far when administering 
of polypeptides and even proteins will not be via injection or infusion.  
 
1.12 Microneedle Design for Autonomous Therapy Systems 
As mentioned earlier, an application-independent optimum design for 
microneedles does not exist. Design selection is highly application specific and involves 
simultaneous consideration of multiple parameters. Common design variables include 
geometric features (length, diameter, shape), choice of material, array layout, physical 
architecture (beveled tip, conical, side-opened) etc. There is always a trade-off among 
the various output characteristics such as fragility, biocompatibility, penetration force, 
fluid flow rates, ease of fabrication, cost etc. Application specific requirements of 
diabetes therapy systems necessitate that certain microneedle characteristics have 
higher priority. Key design issues and related parametric interdependencies specific to 
diabetes therapy systems are discussed below.  
1.12.1 Microneedles for the Sensing Component 
Glucose sensing can be done by sampling either blood or interstitial fluid (ISF). 
The choice of the biofluid sampled is the primary factor determining microneedle design. 
In order to understand design variations between blood extracting microneedles and ISF 
extracting microneedles, it is important to understand physiological differences between 
blood and ISF. 
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Figure 5: Relative insertion depths of microneedles [46] 
 
1.12.1.1 Microneedles for Interstitial Fluid Sampling 
The depth of microneedle penetration needs to be in the approximate range of 
50–150 !m to extract ISF. Such low microneedle height requirement translates to higher 
latitude in design variations. Microneedles have two possible failure scenarios - fracture 
or buckling.  In general, shorter needles, of the same diameter and material, can 
withstand higher pressures without failing. Thus, needles composed of relatively lower 
strength material, e.g. silicon dioxide, can be used for ISF sampling. Silicon dioxide is 
also highly biocompatible, an additional advantage. Reduced height allows for smaller 
needle diameters without inducing buckling [93]. A smaller tip diameter results in a much 
higher ratio of fracture force vs. insertion force into skin [94]. This increases the margin 
of safety for employing microneedles without failure. Microneedle lumen diameters for 
ISF sampling can typically be as low as 10 !m. 
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A small microneedle diameter coupled with the low density of ISF induces 
extremely high capillary forces. Capillary forces also increase with higher hydrophilicity 
of the microneedle material. This facilitates extraction of the fluid even without a 
pumping mechanism. Unfortunately, the flow rate through microneedle declines with 
decreasing diameter [95]. Thus, an initial latent time exists before the microneedles are 
filled with ISF [96].  
Glucose sensing is a good example of ISF extraction, can serve as a model for 
general volumetric analysis. Most commercial ISF glucose sensors require around 0.5!l 
– 2!l of fluid [97], and this figure is continuously decreasing. In order to increase flow 
rates, an array of microneedles is used to achieve the required flow. Vacuum pump 
assisted ISF sampling using microneedles in humans has been demonstrated and 
shown to successfully track changing glucose levels following insulin injection with a 
time lag of less than 20 minutes [98]. 
1.12.1.2 Microneedles for Blood Sampling 
Blood capillaries are present just below the epidermis. Generally blood 
microcapillaries are found at penetration depths of about 400 !m. The nerve tips are 
also present in the same depth vicinity. Thus some microneedles within the array might 
just graze the topmost nerve cells. However the extremely small diameters and 
controlled shank length reduce the odds of encountering a nerve or of stimulating it 
enough to induce pain [99, 100]. Figure 5 depicts the relative insertion depths of 
microneedles used for blood or ISF sampling.  
In order to extract blood without significant pain, microneedle shank lengths need 
to be around 400–900 !m. At these lengths the microneedle needs to be built using 
higher strength materials such as metal or silicon. A common model used by 
researchers is the dimension of the female mosquito proboscis [40, 42]. The 
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microneedle diameter needs to be large enough to allow convenient passage to the 
largest blood cells. Also, the larger length necessitates larger diameters to preclude 
needle failure via buckling. Typical microneedle diameters have to be at least 50 !m 
wide. Even though capillary action alone can be enough to extract blood, factors such as 
higher fluid density, larger conduit diameter, and the material of choice can mitigate the 
effect. In such a case, a microfluidic pumping device is needed to generate negative 
pressure [42]. 
1.12.2 Microneedles for Drug Delivery  
For fluid infusion, flow rates of greater than 1ml/hour for a single microneedle 
have been demonstrated [101]. Even with modest rates, and employing a needle array, 
requisite amount of dosage can be easily transferred via microneedles.  
1.12.3 Fluid Flow Through Microneedles 
Deciding the microneedle array specifications (pitch, size of array) is as important 
as design of the individual microneedle. Microneedles can sometimes get clogged by 
tissue being trapped in a needle lumen during insertion (beveled-tip [102] or side-opened 
[103, 104] needle designs minimize these effects). Employing numerous needles 
minimizes the influence of individual needle failures or passage blockages. Also, as 
mentioned earlier, use of an array formation increases fluid flow rates. The flow rate 
increases linearly with the number of microneedles in the array. However, care has be 
taken not to place needles too close to each other, otherwise a ‘bed-of-nails’ effect can 
result in the skin being pushed down uniformly without penetration [81]. Generally 
microneedles are placed more than 200 microns apart and array size can be as small as 
a few microneedles to hundreds. 
Fluid flow through a microneedle is generally assumed to be laminar. It largely 
depends upon the pressure difference across the needle and is set by the microfluidic 
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pump and the capillary forces. Unfortunately, a fluid-mechanical description of the skin 
has not been established yet, and thus modeling flow through a microneedle is a 
complex task; complicated further by the fact that biofluids generally exhibit non-
newtonian behavior. Various non-linear in-vivo effects such as liquid absorption in the 
epidermis, hindrance to fluid motion due to presence of cells and saturation play a role in 
fluid dynamics. Furthermore, there are present pressure losses due to flow down a 
microneedle. These can be attributed to entrance losses, drag on the duct walls, and 
losses due to specific microneedle geometry (expansions, bends, etc.) [105].  
Basic modified Bernoulli equation is often used as an approximation to model 
fluid flow. 
1)       
"p is the pressure drop, q is the flow rate, K1 and K2 are macroscopic values that 
represent inertial minor losses in piping systems, ! is the density of liquid, µ is the 
viscosity, D is the diameter of needle and L is the length. 
The Hagen-Poiseuille Equation, which describes slow viscous incompressible 
flow through a constant circular cross-section, is generally used to establish rough 
estimates. 
2)  
For n microneedles the net flow rate gets multiplied by a factor of n. 
 
1.13 Contribution to State-of-the-Art 
This research intends to make the following contributions to the state-of-the-art in 
lab-on-a-chip devices: 
1) First study on DNA binding analysis on microfluidic chamber materials. 
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2) Novel use of microfluidic chamber as an active element within a lab-on-a-chip 
device. 
3) First reported fabrication of hollow microneedles with sharpened tips. 
4) First reported study on shear fracture of microneedles. 
5) First reported study on strength testing of silicon dioxide microneedles. 
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CHAPTER 2 
BACKGROUND 
 
Advanced lab-on-a chip systems have the potential to close the loop between 
diagnostic and therapeutic elements of diabetes treatment, thus constituting a ‘smart’ 
system [106]. A microfluidic device consists of various passive and active components. 
Active elements may be micropumps [6, 7], microvalves [8, 9], heaters [27, 28], micro-
sonicators [29], flow sensors [13, 14] among various others. Passive elements may be 
microfluidic chambers [30-32], microfluidic channels [33, 34] or other external interface 
elements such as microneedles. Each of the components of a microfluidic device needs 
special attention to enhance their individual properties. In this research, microfluidic 
chambers as well as microneedles have been studied as components for a typical lab-
on-a-chip device.  
 
2.1 Enhancement of the Microfluidic Chamber: Material Considerations 
2.1.1 State-of-the-Art in Microfluidic Chamber Material Research 
Various chamber materials have been studied individually in research literature. 
Most commonly ‘soft’ materials such as PDMS and PMMA are used to form microfluidic 
chambers, and their properties have been extensively studied [30-32]. Recently there 
have been studies on large scale integration of materials to form lab-on-a-chip device 
[107, 108].  
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However, there hasn’t been any comprehensive study on the relative properties 
of materials with respect to microfluidic chambers. This research aims to fill this gap in 
scientific literature. 
2.1.2 Lab-on-a-Chip Systems for DNA Extraction 
LOC systems are routinely used for applications involving DNA extraction from 
biological cells [38, 39]. A popular application of this type is chromatin 
immunoprecipitation (ChIP) [109]. ChIP is a recently developed laboratory method that is 
useful for analyzing modifications to chromatin, investigating gene expression, 
identifying transcription factor binding, and identifying unknown genes of transcription 
factors.  All of these have relevance to understanding the biology of cancer.  This type of 
immunoprecipitation has been used with increasing frequency in research applications 
over the past 10 years.  Chromatin immunoprecipitation protocols (ChIP) also have 
potential for use as an early detection method for cancer.   
The ChIP process is essentially a protein-DNA binding protocol. The process 
involves formaldehyde crosslinking of proteins to DNA in intact cells, followed by 
extraction of protein-DNA complexes via cell lysis. Subsequent biochemistry steps such 
as antibody binding, reverse cross-linking and protein digestion result in extraction of the 
target DNA. It is imperative that the surfaces on which the reaction is performed are 
thoroughly cleaned after each step because the presence of any DNA impurity in the 
final product is amplified during analysis.  This necessitates that the microfluidic chip be 
made of materials that show the lowest non-specific binding of DNA through the entire 
processing cycle. When not bound (or loosely bound) to the chamber surface, the DNA 
impurities can be easily washed away to a waste chamber. Desirable washing 
characteristics like these make the whole process faster, more efficient, and result in 
higher purity output.   
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A material with attractive properties for use as a base material in microfluidic 
devices is nanocrystalline diamond. Its chemical inertness, optical transparency [110], 
and high thermal conductivity make it suitable for incorporation with both active and 
passive devices, such as channels, mixers, reaction chambers, pumps, heaters, and 
sensors for measuring temperature, flow, impedance, pH, etc [111]. Various microfluidic 
structures have been built using crystalline diamond [112-114]. Researchers have 
functionalized diamond films for various kinds of biological sensing applications [115-
120]. However its value towards specifically biological lab-on-a-chip devices hasn’t been 
fully exploited. Nanocrystalline diamond’s surface smoothness correlates to it being an 
excellent chamber base material for biological entities such as proteins, DNA, cells, etc. 
Nanocrystalline diamond when terminated with hydrogen is a highly hydrophobic 
material, and its hydrophobicity can be controlled by post-deposition processes [121]. 
Consequently, it resists non-specific DNA surface binding. This property is significant to 
biological lab-on-a-chip applications such as chromatin immunoprecipitation. 
Researchers have shown favorable DNA preservation or DNA attachment properties of 
functionalized crystalline diamond [122-124]. These properties coupled with low non-
specific DNA binding demonstrated here enhance nanocrystalline diamond’s potential in 
DNA handling applications. 
 
2.2 Microfluidic Chamber as an Active Element: Enhancement of Cell Lysis 
2.2.1 State-of-the-Art in Cell Lysis on Chip 
Microfluidic chambers usually behave as passive fluid “containers”, with little or 
no active role in device performance. However, for an application such as cell lysis 
within a lab-on-a-chip, the microfluidic chamber can be modified to act as a “mechanical 
catalyst”. 
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Cell lysis is a common procedure in microbiology protocols that requires specific 
implementation in a microfluidic lab-on-a-chip application. Cell lysis in a traditional 
laboratory is typically done mechanically via ultrasonic vibration. This physical method 
has the advantage that it does not require the use of chemical agents which reduces the 
washing in the chip. Ultrasonication has also proven to be highly effective for 
fragmenting DNA and is thus a more efficient lysis method for PCR [125] as opposed to 
electroporation which is another commonly used lysis method. Nevertheless, microfluidic 
lab-on-a-chip applications use chemical lysis [126] or electric fields [127, 128] for cell 
lysis in most cases rather than a micro-sonicator [29]. This in part is due to the inherent 
power limitations of an ultrasonic microresonator which limits the efficiency of cell lysis. 
One solution is to employ disruption microbeads that are introduced in the cell 
suspension to assist mechanical cell lysis [129]. These beads physical pound the cells 
during sonication rupturing cell membranes. Unfortunately, having loose mechanical 
entities in the microfluidic chamber results in complications. The beads may block the 
microfluidic channels, and their introduction into the chamber is a cumbersome task. 
This research explores the use of micro-spikes on the microfluidic chamber walls 
to enhance cell disruption. During ultrasonication the cells collide against the chamber 
walls. During this collision, the array of spikes physically puncture the cell walls 
increasing the efficiency of cell lysis. 
 
2.3 Microneedle Based Skin Interface Systems 
2.3.1 State-of-the-Art in Microneedle Design 
A critical design parameter in the fabrication of microneedles is the compromise 
between structural rigidity and ease of penetration. Due to elasticity of skin, a 
considerable amount of deformation takes place around the insertion site, significantly 
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reducing the insertion depth of microneedles [130]. The outermost layer of the 
epidermis, stratum corneum, is a thin, flexible, high impedance biopolymer composed of 
interconnected dead cells. This layer is the major barrier to various environmental insults 
(climatic, toxic from xenobiotics, or microbial), and needs to be punctured for fluid 
transfer.  Below the stratum corneum lies the viable epidermal layer that is devoid of 
blood vessels and contains very few nerve endings. The thickness of stratum corneum 
and viable epidermis of typical human skin are 10-40 !m and 50-100!m respectively 
[131, 132]. These layers tend to deform rather than puncture upon needle incidence. 
To mitigate the undesirable effects of skin deformation, the pressure applied by 
the needle tips needs to be increased. Insertion pressure can be increased by raising 
the applied force, or, by increasing the needle sharpness.  An increase in applied force 
intensifies the strain on the microneedles and may cause undue breakage. Furthermore, 
it may also magnify the patient’s discomfort. Vibratory actuation has been suggested to 
decrease the force required for insertion [133].  However, this requires the use of a 
vibratory actuator, which may not be possible for all applications, or might complicate the 
design requirements.   
Permeation of microneedles can also be improved by increasing their sharpness. 
However, this is quite often achieved at the expense of structural rigidity.  The needles 
must be capable of tolerating stresses related to the non-uniformity of skin contour, 
inadvertent slippage during insertion or removal, and reasonable human movements 
during period of penetration. Microneedles with extremely sharp tips, but thin needle 
bodies have been employed with successful penetration into skin [134]. However, 
structural damage after insertion was reported, as can be expected due to compromised 
sidewall thickness. 
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2.3.2 State-of-the-Art in Silicon Dioxide Needle Fabrication 
Silicon dioxide being highly biocompatible is a potentially desirable material for 
microneedle fabrication. Silicon dioxide allows for the smallest size of needles possible, 
as compared to any other material. These needles are fabricated by etching silicon 
followed by wet oxidation [71, 72]. 
Traditional fabrication methodologies employ lapping of bulk silicon, which 
dramatically reducing the obtainable length of microneedles. Also, lapping is a harsh 
process, and usually results in an uneven or sloping surface. This research involved 
fabrication of silicon dioxide microneedles using silicon nitride as an etch–stop layer for 
DRIE. The same nitride layer acts as an oxide barrier. This novel use of silicon nitride 
results in no loss of the bulk silicon.  
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CHAPTER 3 
DNA BINDING STUDIES ON MICROFLUIDIC CHAMBER 
 
The goal of this task is to analyze DNA binding to nanocrystalline diamond films. 
Binding experiments were tailored specifically for chromatin immunoprecipitation 
protocol. However results are universally pertinent for other biological microfluidic 
applications. DNA binding tests were performed on nanocrystalline diamond samples 
and compared with common building materials.  These materials were silicon, silicon 
dioxide, Polydimethylsiloxane (PDMS), Poly methylmethacrylate (PMMA), SU-8, and 
glass.  
 
3.1 Materials and Methods 
3.1.1 Substrate Sample Preparation 
In this study, DNA binding was tested on seven materials. Substrate materials 
such as silicon (250 micron, (100), n-type, 10-30 ohm-cm, double side polished) and 
glass (250 micron, Corning 7740) were used as is. Other materials were prepared on 
similar silicon substrates. All materials were deposited on both sides of a silicon wafer to 
ensure similar DNA binding on either side. The following parameters were used – 
PMMA: 3000 rpm, 30 second spin, cure at 180 °C for 5 minutes; PDMS (Sylgard 184): 
3000 rpm, 30 second spin, cure at 150 °C for 30 minutes; SiO2: dry oxidation at 1100 °C 
for 6 hours to give 3000 Å oxide; SU-8 (Series 50): 4000 rpm, 30 second spin, soft bake 
at 65 °C for 6 minutes followed by cure at 95°C for 20 minutes. Nanocrystalline diamond 
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was grown in presence of Ar (371 sccm), CH4 (4 sccm) and H2 (25 sccm) for 6 hours 
(750 °C, 95 torr, 800W RF power). It is well known that nanocrystalline diamond grown 
in high percentage of hydrogen results in a natively hydrogen terminated surface. The 
hydrogen termination results in negative electron affinity at the diamond surface, 
imparting hydrophobic properties.  
All seven types of samples were finally diced into equal sized squares of 6mm x 
6mm to ensure equal area of exposure to DNA. 
3.1.2 DNA Binding Protocol 
 The source of DNA for all experimentation was HeLa S3 (human cervical 
carcinoma) cells.   All tests to expose the substrates to DNA were carried out in 
polypropylene tubes. Substrate material samples were separated into batches; each 
batch containing one piece of each type of substrate. Then, a chromatin 
immunoprecipitation protocol was performed in the presence of each substrate material 
(approximately 2x106 cells for each ChIP) in order expose them to DNA.   Nonspecific 
DNA binding was tested after each of the three major steps of ChIP (cross-linking, 
sonication, and immunoprecipitation).    
The first few experiments were simultaneously performed in the presence of 
extra DNA from a plasmid carrying the specific DNA sequence to be analyzed. This 
extra DNA was used to amplify the response and provided verification of the results.  
The following protocol was performed for each of the ChIP steps. 
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Figure 6: DNA binding after crosslinking 
 
3.1.2.1 Crosslinking 
Seven identical tubes were prepared.  Each contained two samples of a 
particular substrate along with a suspension of cells. Crosslinking was performed by 
adding 1% formaldehyde (in phosphate buffered saline (PBS), pH 7.4) at room 
temperature. The samples were incubated   for ten minutes while being rotated 
simultaneously in a mixer.  This ensured uniform distribution of DNA on the surfaces. 
Crosslinking was stopped using glycine (0.125 M).  The substrate samples were 
removed and washed in a fresh tube containing 200 µl of PBS and vortexing for 10 
seconds. One of the two substrate samples was removed for analysis.  The other 
sample underwent a second wash in a buffered detergent solution (PBS + 1% Triton X-
100). This sample was also removed and placed into a fresh tube for analysis. 
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Figure 7: DNA binding after sonication 
 
3.1.2.2 Sonication 
The cells remaining from the crosslinking step were centrifuged at 4 x g for 5 
minutes. The supernatant was removed. Then, 1 ml of sonication buffer (50 mM HEPES, 
pH 7.8, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100) was added and the cells were 
resuspended. Two unused samples of the each substrate material were added to seven 
different tubes. All tubes were kept on ice from this point forward. Sonication was 
performed three times for 10 seconds at 5 watt power output. The two samples were 
removed, one was subjected to a single wash and the other was washed twice as 
described in the crosslinking step.   Both samples were then kept in fresh tubes for 
analysis. 
3.1.2.3 Immunoprecipitation 
Two new samples of the each substrate material were added to seven different 
tubes. The solution remaining from the sonication step was centrifuged at 10 x g for 10 
minutes. Due to fragmentation of cells and DNA in the sonication step, the DNA was 
present in the supernatant. 500 µl of this supernatant was added to each of the seven 
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tubes along with 100 µl of an immunoglobulin (IgG) specific to the target DNA which was 
lanosterol synthase gene.  This gene was chosen because it is present as a single copy 
in the human genome. This IgG was conjugated to agarose beads. The samples were 
incubated for 3 hours with continuous mixing at 4 °C. Both the samples in each tube 
were washed and removed for analysis as described above. 
 
 
Figure 8: DNA binding after immunoprecipitation 
 
3.1.3 Residual DNA Binding Analysis 
All samples for analysis were heated to 95 °C in fresh tubes containing water for 
10 minutes. Heating released the residual DNA from the sample surface into the water. 
Polymerase chain reactions (PCR) was performed using this solution (95°C 15 seconds, 
55°C 30 seconds, 45°C 72 seconds for 34 cycles) in order to amplify the DNA. For the 
PCR reaction the following oligonucleotides were used.  Sense: AGT GCT TGG TGA 
GGC AGTTT; Antisense: CCT ACC CCC AGC CTA ACT TC. Visualization of amount of 
DNA in the PCR output was done using an ultraviolet transilluminator. The output 
intensity from the transilluminator was translated into the amount of DNA in each 
sample. It should be noted that the output obtained from the transilluminator sometimes 
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contains ‘smeared’ bands, instead of a single sharp one. This is a common result due to 
overamplification of the PCR product, insufficient prior dilution, or too much genomic 
DNA [135]. However, since all samples within a particular graph undergo PCR 
amplification simultaneously, the results are still valid. The center sharp band is used for 
comparison in these cases. 
As previously mentioned, the first set of experiments was also performed along 
with plasmid carrying the target DNA. Non-plasmid carrying samples were also tested 
simultaneously for control. All samples in this set of experiment underwent only one 
wash.  
 
 
Figure 9: Single and double wash DNA binding after crosslinking 
 
3.2 DNA Binding Analysis 
Figure 6 compares the quantity of DNA removed from each substrate surface for 
the crosslinking protocol done without the plasmid DNA with same experiment done in 
the presence of plasmid DNA. The intensities obtained from the transilluminator are 
shown below each corresponding bar. Lower bar height depicts lower non-specific 
binding. Figure 7 and Figure 8 depict the results from the sonication and 
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immunoprecipitation steps, with and without the plasmid DNA. These results also depict 
similar trends. It is clear from the results that DNA exhibited the least binding to nano-
crystalline diamond.  These results are corroborated by the fact that they correspond 
very well with the set containing the plasmid DNA. Since it was evident that good 
amplification was obtained even without the plasmid DNA, this approach was discarded 
in further experiments. 
 
 
Figure 10: Single and double wash DNA binding after crosslinking 
 
 
Figure 11: Single and double wash DNA binding after immunoprecipitation 
 
Figure 9, Figure 10 and Figure 11 show outputs from double wash experiments.  
There was an evident drastic decrease in the amount of DNA bound in all samples, due 
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to the extra wash. However, note that all analyses were performed on separate samples. 
Also, PCR on the one wash samples was done separately from the two wash samples. 
Thus we cannot accurately quantify the percentage decrease in binding due to a wash. 
Nevertheless, all results indicate nanocrystalline diamond consistently resulted in the 
lowest quantity of non-specific DNA binding. Thus, it is potentially capable of offering 
high sensitivity / high throughput when used in lab-on-chip devices. 
However, nanocrystalline diamond has non-trivial overheads in form of 
integration complexity and cost. The results show that SU-8 exhibited relatively on low 
non-specific binding as well. This material is highly conducive to fabrication of 
microfluidic devices, and may be a better option as a material, it might offer the best 
compromise  between sensititivity and ease of fabrication. Even though glass is widely 
used, it consistently showed the worst non-specific binding, and thus can be concluded 
to be an undesirable material when sensitivity and throughput are of importance. 
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CHAPTER 4 
CELL LYSIS ENHANCEMENT VIA NCD MICROSPIKES  
 
4.1 Introduction 
This research explores the use of micro-spikes on the microfluidic chamber walls 
to enhance cell disruption. During ultrasonication the cells collide against the chamber 
walls. During this collision, the array of spikes physically puncture the cell walls 
increasing the efficiency of cell lysis.  
 
Figure 12: Sketch of cell lysis unit 
 
For this study, the material of choice for the micro-spikes was nanocrystalline 
diamond (NCD). This research builds on the DNA binding research [136] which explores 
the use of nanocrystalline diamond for microfluidic lab-on-a-chip, and establishes that 
NCD exhibits the most resistance to non-specific DNA binding when compared to 
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commonly used lab-on-a-chip building materials such as silicon, silicon dioxide, PDMS, 
PMMA, glass and SU-8. 
NCD is uniquely suited for cell lysis applications as its mechanical properties 
[137] ensures that the micro-spikes would be the most robust to survive the vigorous 
mechanical collisions they would be subjected to. Furthermore, NCD being a crystalline 
material with a small grain size, a pyramidal spike-like structure made with it results in an 
extremely sharp nanocrystalline tip. An increased efficiency of cell lysis via 
ultrasonication would greatly increase the possibility of using mechanical lysis 
techniques in lab-on-a-chip applications. 
 
4.2 Fabrication of Microfluidic Chamber 
The focus of this study was to evaluate the effect of using micro-spikes on cell 
lysis via ultrasonication. The method of sonication was not the focus of this study 
because different implementations might use a preferred type or design of sonicator.  
The underlying physics behind cell lysis via ultrasonication would remain the same, 
irrespective of the design of the sonicator. For this study a horn type ultrasonicator was 
used for cell disruption. 
Custom designed cell lysis units were built using polycarbonate (Lexan from GE). 
Figure 12 schematically illustrates the chamber design, which included a microfluidic 
chamber of 200 !l volume machined into a Lexan sheet. A similar sized thinner piece of 
Lexan sheet was used to fabricate cover pieces for each microfluidic chamber.  Identical 
holes for screws were drilled through the cover pieces and into the chambers. A thin 
rubber seal was placed in between each chamber and the cover piece to prevent 
leakage, and screws were used to secure the pieces together, after loading the cells.  
The rubber seal contained a rectangular cutout of exact dimensions of the chamber 
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cross-section. The cutout was made to prevent the cells within the chamber from coming 
in contact with the rubber seal.  
Cell suspension of B16-F10 (ATCC CRL-6475) murine melanoma cells was 
introduced into each microfluidic chamber via a micropipette. The rubber seal was then 
aligned and placed over the chamber. The Lexan cover piece was placed on top of the 
rubber seal, and the entire stack was tightened together with four screws, resulting in a 
watertight seal. 
 
Figure 13: Fabrication process flow of nanocrystalline diamond microspikes 
(enhanced chamber flooring) 
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 Two types of cell lysis units were built for the purpose of this study. The first 
type of unit) had a planar floor within the microfluidic chamber (henceforth referred to 
as a ‘plain unit’. The other had nanocrystalline diamond microspikes at the bottom of 
its microfluidic chamber (henceforth referred to as an ‘enhanced unit’). Figure 12 
depicts an enhanced cell lysis unit.  Several identical cell lysis units of both types 
were built to perform simultaneous or subsequent experimental runs with varying 
conditions. All units were identical in every respect except for the surface of the 
flooring. MEMS processing techniques were used to fabricate the ‘enhanced’ 
flooring. Bare glass was used as the flooring for the plain units. The glass substrates 
were permanently fixed into the Lexan cavities using cyano-acrylate adhesive, thus 
forming the microfluidic chamber. 
 
4.3 Fabrication of NCD Microspikes 
Figure 13 schematically illustrates the process for fabrication of the microspikes.  
Standard MEMS fabrication processes were used to make the flooring for the enhanced 
cell lysis unit. A (100) n-type silicon wafer was used for fabrication. Wet oxidation of 
silicon was performed to produce a 3000 Å silicon dioxide layer. Silicon dioxide was 
patterned using lithography and wet etching via buffered oxide etch (BOE).  The mask 
used was comprised of an array of squares of 5 micron edge length having a pitch of 20 
microns. Wet anisotropic etching was then performed using 25% KOH at 90ºC for about 
10 minutes. This resulted in micropyramidal pits being formed on the silicon substrate 
which were used as a template for the microspikes. This size of spikes’ base was 
chosen because it is approximately same as the diameter of the cells. 
  The oxide mask was then removed using BOE. The patterned sample is then 
ultrasonically pretreated in a mixture of nanodiamond and acetone slurry for 20 
minutes followed by a sequence of ultrasonic rinse and clean steps.              
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Figure 14: a) Optical image of NCD microspikes on glass substrate showing spike-like 
structures b) SEM images of an array of microspikes c) SEM image of a single NCD 
microspike. 
 
The nucleation density achieved by this method of seeding is on the order of 
1010cm-2. The nanocrystalline diamond (NCD) films were grown in a Cyrannus I Iplas 
microwave-plasma enhanced chemical vapor deposition (MPECVD) reactor using 0.5 % 
methane, 1 % hydrogen and remaining balanced with argon. The process parameters 
were: Pressure - 135 Torr, Substrate temperature - 725°C, and a microwave power of 
1.8 KW. The thickness of the NCD film was estimated to be ~ 1.5 micron. A 2 micron 
layer of PECVD silicon dioxide was then deposited over the nanocrystalline diamond. 
This layer served as an adhesion layer between the NCD layer and the subsequently 
deposited gold layer. It also serves to fill up most of the pyramidal cavity, planarizing the 
surface to some degree. This is followed by evaporation of 3000 Å of gold (over 300 Å of 
chrome adhesion layer).  Electroplating of gold is then performed to produce a 1.8-2 
micron layer. The thick layer of gold completely planarizes the surface of the wafer. The 
47 
electroplating was done at a high current density to result in a softer gold layer and thus 
more conducive to thermocompression bonding.  
A glass wafer (Corning 7740) was taken separately and similar evaporation and 
electroplating processes were performed on it. The two wafers were then bonded via 
thermocompression bonding of gold at 400N force for 20 minutes using an EVG 501 
universal bonder. This results in a glass-gold-SiO2-NCD-Si stack. The entire stack was 
then subjected to a 25% TMAH etch at 95ºC until all the silicon was dissolved (about 8 
hours). This resulted in upright nanocrystalline diamond spikes over a glass substrate. 
Figure 14 shows an image of the spike like microspikes taken through a high 
magnification optical microscope. The image was taken at an angle to show the 
microspikes, and thus only part of the image is in focus. 
The glass wafer was then diced to required dimensions in order to precisely fit 
the Lexan cavity. Bare glass wafers were also diced to the same dimensions forming 
floorings for the plain cell lysis units. 
 
4.4 Experimental Protocol 
This study was conducted using B16-F10 (ATCC CRL-6475) murine melanoma 
cells. The adherent B16 cells were grown in standard tissue culture flasks (Costar 3000; 
Corning Inc., Corning, NY) in McCoy’s 5A medium (MediaTech Inc., Herndon, VA) 
supplemented with 10% (v/v) fetal bovine serum (MediaTech Inc., Herndon, VA) in a 37 
°C humidified atmosphere that contained 5% CO2.   Cells were prepared for 
experiments by trypsinization and then washing the harvested cells by centrifugation 
(225 x g) 3 times in phosphate buffered saline.   The resulting washed cell suspension 
was further prepared by determining viability using the trypan blue dye exclusion test.  
Cell cultures that were >95% viable were used for experimentation. Before each 
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experiment, the suspension of harvested cells was adjusted to a concentration of 1 
million cell per ml based upon enumeration in a standard hemacytometer. 
 Each experimental set employed three cell lysis units. The first unit was a 
control unit, which did not undergo any sonication (a plain cell lysis unit was used). The 
other two units were a plain and an enhanced cell lysis unit, both of which underwent 
sonication. 75 µl of cell suspension was introduced at the same time into all three 
microfluidic chambers. The plain and enhanced units were immersed in water (inside a 
beaker), and an ultrasonic horn was used for lysis (Misonix – Sonicator 3000, #” probe – 
misonix part #200, operating amplitude 120 !m, operating frequency 20kHz). The 
sonication was carried out for 2 minutes at 69W. After sonication, cell lysis units were 
opened and 50 µl of SYTOX green dye was mixed with all three cell suspensions. 
SYTOX Green dye is an unsymmetrical cyanine stain with three positive charges and 
has a high-affinity for nucleic acids. The dye cannot penetrate the intact membranes of 
live cells, but easily penetrates cells with compromised plasma membranes.  The dye 
exhibits a 100 to 500-fold increase in fluorescence when it is bound to any kind of 
nucleic acid that is present inside cells. Hence the dye fluoresces when it penetrates 
lysed cells and binds to nucleic acids, or when it binds to nucleic acids that are outside 
the cell. Therefore, it is an indicator of lysed cells. Spectrafluorometric analysis was 
performed on all three samples.  Comparison of fluorescence data from the cell 
suspensions was a measure of the relative amount of lysed cells. Thus, by comparing 
the fluorescence the relative efficiency of the cell lysis can be evaluated.  
 
4.5 Results 
Multiple sets of experiments were carried out using the above protocol. Each set 
contained a control unit (no sonication), a plain cell lysis unit and an enhanced cell lysis 
unit. Within each set, cells from the same harvested crop of B16 cell were used to 
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ensure equal number of cells is present in each unit. Care was taken that the cells are 
introduced into the microfluidic chambers at the same time, to ensure equal viability of 
cells. Every separate set of experiment was performed with a different crop of cells to 
establish a definitive trend.  Half of the sets employed cell suspensions without any cell-
disruption beads. The other sets used 0.5 mm diameter glass cell-disruption beads. Ten 
glass beads were introduced into each chamber along with the cell suspension, and the 
cell-lysis protocol was carried out. Figure 15 depicts the results obtained from different 
sets of experiments that did not use the disruption beads.  Figure 16 depicts results with 
sets using glass beads. 
 
Figure 15: Ultrasonic cell lysis (without disruption beads). 
 
Typically, there were a few nonviable cells in any prepared batch of B16 cells.  
These cells represent the normal quantity of dead cells in any culture, losses in viability 
due to repeated centrifugation, pipetting, and other manipulations that were necessary to 
have an enumerated cell suspension to load into the chambers.  As noted above, all 
cells use for these experiments were >95% viable. Since a single cell suspension was 
used for all units within a set, and the units were employed concurrently.  Therefore, the 
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fluorescence data for control samples represents the minimum number of nonviable 
cells.  This number was also present in the ultrasonically treated samples; therefore, 
increases in fluorescence in these samples could be attributed to ultrasonic lysis. 
 
Figure 16: Ultrasonic cell lysis (with glass disruption beads) 
 
Three sets of lysis experiments (without beads) were repeated and the numbers 
of alive cells were counted in the control, plain and enhanced cell lysis unit using a 
standard hemacytometer. Figure 17 depicts the concentration of viable cells after 
completion of the sonication. The starting viable cell concentration was 1 million/ml. 
Time required for experimental run was about an hour and the loss in viable cell 
concentration of the control is typical for this period. It is evident from the results that the 
efficiency of cell lysis via ultrasonication was greatly enhanced when micro-spikes were 
present on the chamber walls. The increase in cell-lysis efficiency was consistent across 
all sets of experiments. It should be noted that each set of experiment was performed 
with a different cell crop; thus the total number and viability of cells varied slightly from 
set to set. It can be seen in Figure 15, that plain sonication resulted in a very small 
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increase in fluorescence that averaged about 28%.  However under the same 
conditions, the presence of spikes at a chamber wall resulted in 392% increase in 
fluorescence relative to the controls. 
 
Figure 17: Concentration of viable cells after sonication 
 
In the experiments where glass beads were present, the efficiency of cell lysis 
was found to be greater than that without beads. As seen in Figure 16, with beads 
present the fluorescence increased by an average of 93%. Thus the beads assist to a 
certain degree in cell lysis via ultrasonication when compared to the control and the 
same treatment that did not use beads. However, the fluorescence of samples in the 
enhanced unit recorded a 414% increase with beads being present. In the cell count 
experiments, the concentration of viable cells remaining in the enhanced chamber is 
nine times less that those in the plain chamber.   
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4.6 Conclusion 
The results verify that a substantial increase in cell lysis efficiency can be 
obtained by using micro-spikes along the microfluidic chamber walls. Even when spikes 
were present only on one chamber wall, the increase in dead cell count was about 400% 
- substantially more than without spikes. The efficiency of cell lysis should increase even 
further if similar micro-spikes are used on multiple walls.  
Even though use of glass disruption beads increased the cell lysis efficiency, this 
increase was not as pronounced as that with use of micro-spikes. It is interesting to note 
that with use of microspikes, the efficiency benefits of using disruption beads become 
minimal (414% vs. 392%). For a typical microfluidic application, the inherent 
disadvantages and inconvenience of handling glass beads in a lab-on-a-chip would 
greatly overshadow the performance benefits.  
It was seen that even after repeated use for ultrasonication and intermediate 
wash cycles, performance of the nanocrystalline diamond microspikes did not decrease. 
Thus, NCD proved to be a robust material for such an application. Upon visual 
inspection, the microspikes survived multiple experiments without any discernable 
damage. The authors envision that portable lab-on-a-chip applications that use MEMS 
based ultrasonicator for cell lysis would greatly benefit from such a microfluidic chamber 
construction due to their inherent power limitations.
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CHAPTER 5 
SILICON MICRONEEDLES 
 
5.1 Introduction 
Advanced bioengineered systems have the potential to close the loop between 
diagnostic and therapeutic elements employed in modern treatment techniques, thus 
constituting a “smart” system.  Many such systems will involve the transfer of physical 
entities through the skin. Traditional approaches used to collect biofluids or deliver drugs 
through the skin include needle puncture, electroporation or removal of the stratum 
corneum through gels or tapes; all being reasonably intrusive.  A minimally invasive 
method for sampling or delivering biological fluids is essential to autonomous therapy 
systems. Microneedles can achieve this task with significantly less trauma since their 
sharp tips and short lengths reduce the odds of encountering a nerve. 
The outermost layer of the epidermis, stratum corneum, is a thin, flexible, high 
impedance biopolymer composed of interconnected dead cells. This layer is the major 
barrier to various environmental insults (climatic, toxic from xenobiotics, or microbial), 
and needs to be punctured for fluid transfer.  Below the stratum corneum lies the viable 
epidermal layer that is devoid of blood vessels and contains very few nerve endings. The 
thickness of stratum corneum and viable epidermis of typical human skin are 10-40 !m 
and 50-100!m respectively [131, 132].  
A critical design parameter in the fabrication of microneedles is the compromise 
between structural rigidity and ease of penetration. Due to elasticity of skin, a 
considerable amount of deformation takes place around the insertion site, significantly 
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reducing the insertion depth of microneedles [130].  To mitigate the undesirable effects 
of skin deformation, the pressure applied by the needle tips needs to be increased. 
Insertion pressure can be increased by raising the applied force, or, by increasing the 
needle sharpness.  An increase in applied force intensifies the strain on the 
microneedles and may cause undue breakage. Furthermore, it may also magnify the 
patient’s discomfort. Vibratory actuation has been suggested to decrease the force 
required for insertion [133].  However, this requires the use of a vibratory actuator, which 
may not be possible for all applications, or might complicate the design requirements.   
Permeation of microneedles can also be improved by increasing their sharpness. 
However, this is quite often achieved at the expense of structural rigidity.  The needles 
must be capable of tolerating stresses related to the non-uniformity of skin contour, 
inadvertent slippage during insertion or removal, and reasonable human movements 
during period of penetration. Microneedles with extremely sharp tips, but thin needle 
bodies have been employed with successful penetration into skin [134]. However, 
structural damage after insertion was reported, as can be expected due to compromised 
sidewall thickness. 
In this study, hollow microneedles with sharpened sidewall tips have been 
fabricated without any reduction to the needle shaft diameter. Since the microneedle 
sidewalls are sharpened only at the tip and not over the entire length of the needle, the 
mechanical stiffness is maintained, while reducing the insertion force. The outlined 
process achieves needle formation and tip sharpening in a continuous single-step 
process, greatly reducing the complexity of fabrication. Using this process, extremely 
sharp sidewalls can be obtained greatly reducing the penetration force. Furthermore, 
since the process uses dry etching, a simple change in etch recipe can result in different 
sidewall tip angles. 
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5.2 Fabrication of Silicon Microneedles 
The silicon microneedles were fabricated using a 4 inch, 400 !m thick, <100> 
oriented, double side polished silicon wafer. The lithographic mask set contained various 
microneedle arrays with sizes ranging from 33 gauge to 36 gauge. First, lithography was 
performed on the backside of the wafer using photoresist AZ P4620. This step patterned 
the wafer with circular holes outlining the through-wafer microfluidic channels for fluid 
delivery. Next, DRIE was performed on the backside of the wafer, forming approximately 
200 !m deep holes. Lithography was then performed on the front side of the wafer, 
again using photoresist AZ P4620. The corresponding mask used was a bright field 
mask, which patterned annular rings on the front side of the wafer. This step outlined the 
microneedle sidewalls. Next, DRIE of silicon was done to form the microneedles.  This 
step was precisely timed to obtain the desired length of the needles.  
It is important to note that no hard mask is used for etching the microneedles. 
This is because the sharpening of the microneedle tips depends upon controlled 
depletion of the photoresist. Depending on the duration of the second DRIE step, the 
etching at this step might cease before the desired needle lengths are obtained.  This is 
because due to loading effects in DRIE the needle bores etch faster than the exposed 
bulk region of the wafer. As soon as a through-hole is formed at any part of the wafer, 
helium present at the backside of the wafer (for cooling) escapes into the main chamber, 
breaking the plasma. At this stage, the wafer needs to be mounted on an aluminum 
chuck to proceed with further etching. A thermal grease (Cool-GreaseTM) is used at the 
backside of the wafer to dissipate heat. DRIE of silicon is continued for the requisite time 
remaining. The wafer is then solvent-cleaned to remove the photoresist and the thermal 
grease. 
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5.2.1 Sharpening of Microneedle Tips 
The sharpening of microneedle tips is based on precise timing of the second 
DRIE step and controlled depletion of the photoresist.   In the Alcatel DRIE system at 
USF, the photoresist gets depleted at approximately 0.16 to 0.20 !m/minute during 
silicon DRIE via Bosch process.  Thus, the maximum length of microneedles that can be 
obtained is limited by the thickness of photoresist used.  When most of the photoresist 
has been depleted (less than 1.5 !m thick), the resist loses its resolution, and starts 
getting etched from the sides as well. Thus, it is observed that for the last few minutes 
before complete depletion, the feature width of the resist reduces resist gradually. This 
reduction of resist feature width corresponds to reduction of the annular ring area 
forming the protective mask. The outer diameter of the annular ring gets reduced while 
the inner diameter increases.  
 
 
 
Figure 18: Sharpening of microneedle needle tips via gradual reduction of photoresist 
mask 
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Figure 19: Fabrication process of sharpened silicon microneedles 
  
The gradual change in photoresist mask size during the DRIE causes a tapered 
etch profile to be created. This has been depicted in Table 1. The taper angle depends 
upon the etch rate of silicon as well as the depletion rate of photoresist, i.e. the etch 
selectivity. By reducing the selectivity between photoresist and silicon, a higher taper 
angle can be obtained.  
A reduction in selectivity can be brought about by appropriate changes in the 
DRIE recipe. In general, anisotropic etch processes depend heavily on ion-driven 
chemical interactions between adsorbed fluorine-containing species and the silicon 
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surface. Maximum etch rate conditions are achieved when the residence time of reactive 
species is increased by using a lower total gas-flow rate or when the partial pressure of 
the reactive precursor gas is increased. The plasma-generated neutral chemical species 
do not readily etch the silicon surface, but do play a role in the photoresist etching. By 
changing the interactive physical and chemical etching of photoresist and silicon the 
selectivity can be varied. This is usually implemented in plasma etch systems by 
independently controlling the power input to the plasma and the bias voltage applied to 
the wafer. The relative numbers of neutral species and reactive ions depend on the 
specific plasma operating parameters such as RF power input, gas residence time in the 
plasma zone, total reactor pressure, and partial pressure of the individual precursor 
gases [138]. In general, an increase in selectivity is brought about at the expense of a 
reduced etch rate. 
The vertical length of the taper profile was observed to vary from approximate 30 
!m to 40 !m. It is important to precisely time the etch duration. As soon as the entire 
resist is depleted, the microneedles are completely exposed to DRIE etching. The etch 
rate observed in the Alcatel DRIE system ranges from 4 !m/minute to 10 !m/minute, 
depending on the loading effect due the particular mask design. Thus, even a few 
minutes of over etch can result in complete loss of the needle tip. At this stage, the 
needle tip etches at about the same rate as the wafer base, thus limiting the maximum 
length of the needle. The microneedle, very quickly becomes blunt during the over etch 
phase. Table shows the thickness of the photoresist along with the corresponding 
maximum length of microneedles obtained. 
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Table 1: Dependence of maximum microneedle length on photoresist thickness 
Photoresist mask 
thickness (AZ P4620) 
Maximum length 
of microneedles 
6.2 !m 120 !m 
7.6 !m 150 !m 
10.3 !m 200 !m 
 
Figure 20 shows SEM images of a partially tapered silicon microneedle. The top 
view shows the tapering of a 45 !m sidewall down to 25 !m.  
 
 
 
 
 
 
 
 
Figure 20: Partially tapered silicon microneedle 
 
As etching proceeds, further sharpening of the microneedle takes place. Figure 
21 shows SEM images of microneedles with further sharpened tips. Figure 22 shows the 
top view of a silicon microneedle clearly depicting sharpening of the needle sidewall from 
about 43 !m to less than 8 !m. 
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Figure 21:  Silicon microneedles with sharpened tips 
 
 
Figure 22: Top view of silicon microneedle showing extent of tip tapering 
 
At the precise point of the complete resist depletion extremely sharp needle tips 
can be obtained. This is seen in Figure 23. The tip of these needles is in the sub-micron 
range. 
61 
 
Figure 23: Silicon microneedles with extremely sharp tips 
 
It is essential to note that the tapering process takes place particularly fast as 
compared to the preceding etching process. To obtain 200 !m long microneedles, a 55 
minute DRIE etch is required. However, even a few minutes of over-etch beyond that 
resisted depletion causes the needle tip to be compromised; resulting in blunt needles 
as shown in Figure 24. Thus, extremely tight control of obtained photoresist thickness, 
lithography and DRIE are required for successful fabrication. 
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Figure 24: Over-etched silicon microneedles with blunt tips 
 
5.2.2 Electron Shading and Micromasking Effect 
It was observed that, when wafers of higher resistivity (100 to 200 ohm-cm) were 
used, spike-like projections were formed at the inner and outer edge of the microneedle 
sidewalls, as seen in Figure 25.  This effect can be attributed to pattern dependent 
charging in plasmas. In plasma processing, there exists a significant difference in 
directionality between ions and electrons bombarding surfaces. This is a fundamental 
consequence of ‘plasma sheath’ dynamics. Most of the ions impinge onto a wafer 
surface at directions closer to the surface normal while most of the electrons arrive at 
oblique angles of incidence. Thus, the electron flux is isotropic and the ion flux is 
anisotropic along the surface normal. Current balance is accomplished when equal 
fluxes of ions and electrons impinge onto each surface segment. The directionality 
difference has no important repercussions for flat surfaces. However, it can significantly 
perturb the current balance when the surface is patterned as a result of geometric 
shading from the oblique electrons by the features that constitute the pattern [139]. The 
phenomenon, termed “electron shading” [140]. In the case of microneedles, due to 
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electron shading, there is a lack of ion flux impinging on the microneedle sidewalls. This 
results in local negative charge build-up at the entrance of the trenches [141].  
Due to the negative charge accumulation, positively charged reactive ions get 
deflected away during DRIE etching. The greatest charge accumulation occurs at the 
edges of the features. Thus the polymer deposited at the edges of the features during 
the passivation step of the Bosch process, does not get completely etched away. This 
remaining polymer acts like a small mask, resulting in ‘micromasking’. Due to the micro-
masking effect silicon spikes are formed at the edges of the microneedle sidewalls.  
These spikes are also sometimes known as ‘black silicon’ or ‘silicon grass’ [142, 143]. 
The spikes formed due to electron shading and micromasking were removed by 
a 45 second isotropic etch in an SF6/O2 plasma. 
 
 
Figure 25: Silicon spike formation due to electron shading and micromasking effects 
 
5.3 Skin Penetration Testing of Microneedles 
 In order to ascertain the advantage of microneedle tip sharpening, the variation 
of skin penetration force with tip geometry was studied. 34 gauge needles etched to 
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different levels of needle tip sharpness were fabricated, and the corresponding 
penetration force was tested. Tests were carried out on human cadaver skin preserved 
at -80°C. 
The experimental setup consisted of a skin loading block and a needle 
attachment block. The skin was mounted on in the 0.5 inch x 0.5 inch aluminum block 
using double sided adhesive tape. The aluminum block, in turn, was attached to a 
pension-compression load cell (LCFA-500gF sensing capacity, Omega Co.). The 
internal construction of these load cells consists of a full four-arm Wheatstone bridge, 
capable of producing repeatable measurements. The load cell was interfaced to one 
channel load cell input, 16-Bit, RS-485 Data Acquisition Module (Superlogics-8016) to 
obtain real time results. The load cell was supported on a steel block, mounted on a XY 
stage with two 1 !m resolution manual micrometers screws (SM-13, Newport Co.). 
A 4x4 array of 34 gauge silicon microneedles with 1000 !m pitch was mounted 
on the needle attachment block using double-sided adhesive tape. This block was 
supported on an XYZ stage with motorized micrometers (Z600 series Thorlabs 
Motorized Actuators) with 1 !m resolution. The motorized actuators were controlled by a 
custom-built LabVIEW program, which also displayed the real-time output from the load 
cell. Real-time visual monitoring of the needle insertion was done by a long-distance 
high magnification microscope. Video capturing was done via a camera mounted on the 
microscope. 
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Figure 26: Skin penetration testing setup using motorized actuators 
 
 
Figure 27: Visual monitoring of microneedles insertion into skin 
 
The skin was loaded on the load cell immediately after bringing it to room 
temperature. At this point, and the reading from the load cell was allowed to settle down 
for a few minutes. The micrometer actuators allow for precise control of the needle and 
skin position. Through careful monitoring via the microscope, the needles were brought 
extremely close to the skin surface as seen in Figure 27. In order to obtain reliable force 
data, the microneedles were inserted at a slow rate off 50 !m/minute into the skin. The 
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force output from the load cell and the distance travelled by the micrometer actuator 
were recorded via the data acquisition system. 
During microneedle insertion, the skin initially resists the penetration of the 
needles.  This is observed as a rise in the force output from the load cell. At the point of 
microneedle insertion, the stratum corneum is ruptured and the needles undergo a 
sudden movement into the skin. This sudden movement is translated by the load cell as 
a corresponding drop in the measured force. All microneedles were observed to remain 
intact after removal from skin. 
 
 
Figure 28:  Insertion force of silicon microneedles 
 
Figure 28 depicts a graph of monitored force versus distance travelled by the 
microneedles. From the graph, the particular set of microneedles used required a force 
of about 180 gf to penetrate into skin. 
In order to confirm that the force drop observed was indeed due to presence of 
needles, a control experiment was carried out. In this case, a square piece of silicon 
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wafer of the same size as the microneedle array was used instead, and pressed against 
the skin. Figure 29 shows a typical result obtained from the control experiment. The 
graphs obtained from the control experiments overlap with high degree of agreement 
with the microneedle insertion tests. This shows that the skin deformation dynamics 
remain similar in both cases.   
 
Figure 29:  Skin insertion control test without microneedles 
 
5.3.1 Analysis of Microneedle Insertion Into Skin 
Initial indentation into skin is accompanied by deformation of the skin surface. 
Such deformation is typical of microneedle insertion into skin. For the purpose of 
rudimentary analysis, the force transducer can be assumed to be a spring gauge. The 
force measured by the gauge is translated from the compression of the spring. The 
measured force gets compromised due to deformation of the skin. 
Let CN be the compression of the spring at various intervals (N=1, 2, 3 etc.). Let 
MN be the corresponding movement of the microneedles, and let SN be the deformation 
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of the skin. The actual compression of the spring is mitigated by the skin deformation. 
Therefore,  
1) CN = MN – SN   
By Hooke's law (for spring constant K and Force FN): 
2) FN = - K x CN 
3) FN = - K x (MN  - SN)     
4) MN = - FN/K + SN      
For the lower range of movement, the skin deformation is comparable to the 
microneedle movement, i.e. SN is in the same magnitude range as MN. 
The graph plots FN vs. MN. From equation 3, it is clear that due to SN the graph 
can be expected to be non-linear in the low range of needle movement. This is indeed 
observed in Figure 28. As the needles continue further movement, the incident force on 
the skin increases. This is accompanied by an increase in spring compression. However, 
as the skin reaches its deformation limit, the value of SN starts becoming negligible as 
compared to the microneedle movement MN. From equation 3 it is clear that as MN and 
FN increase, and SN becomes comparatively negligible, the graph should start to become 
linear. This again is observed in Figure 28. 
The stratum corneum is the hardest layer of the skin. As soon as the stratum 
corneum is ruptured, the lower layers of the epidermis provide much lower resistance to 
the microneedle insertion. Thus it is expected that as soon as the insertion occurs, most 
of the entire length of the needles get inserted into skin. It has been reported in literature 
that due to skin deformation, the length of the needle penetrating into skin gets limited 
and the entire length of needle does not penetrate [130]. 
The proposed insertion mechanism of microneedles into skin has been depicted 
in Figure 30. Initially, the microneedle forms a slight indentation on the top surface of 
skin as shown in Figure 30-a. As the microneedle moves further, the skin deformation 
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increases, as shown in Figure 30-b. The skin gets deformed before rupturing due 
inherent resistance to penetration. The amount of resistance ability of skin can be 
thought of as a potential energy stored within it. When the energy incident via the 
needles surpasses the potential energy within the skin, penetration occurs. At this point, 
the penetration is relatively instantaneous, especially at high insertion forces. Figure 30-
c shows a post-insertion sketch of the microneedle. At the instant of penetration, the skin 
(which is being pushed by the spring gauge at its back), moves slightly towards the 
needle array, thus registering a force drop. As shown in the figure, as soon as the 
stratum corneum ruptures, the microneedle travels as deep as possible into the skin. 
The base of the array now touches the skin surface.  
 
Figure 30:  Microneedle insertion mechanism into skin 
 
As seen from Figure 27, the thickness of the skin was much a higher (couple of 
millimeters), as opposed to the 200 micron long needles. Thus, the needles are not 
expected to touch the aluminum back-plate behind the skin. After the instant of insertion, 
the silicon base continues to push against the skin, and the force registered continues to 
rise in a similar fashion to the control experiment. 
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5.4 Insertion Force Variation With Tip Geometry 
To ascertain the variation of skin insertion force with variation in microneedle tip 
geometry, microneedle arrays of the different tip sharpness were fabricated. A 4x4 array 
of 200 micron long, 33 gauge needles were used for this analysis. Arrays with four 
different sharpness levels were compared; completely blunt tip, partially sharpened tip 
and very sharp tip. Fresh piece of cadaver skin was used for each of these tests. Care 
was taken to perform the experiments immediately after the skin thawed out. This 
ensured that drying of the skin did not play a role in the penetration measurements. 
Table 2 shows the different needles used for the skin insertion tests. 
Three sets of measurements were taken using each of the microneedle arrays 
under investigation. The incident force applied by the needles was plotted against the 
distance moved by the needles. The motorized actuators allowed for very precise control 
of the distance moved by the needles. 
Except for the blunt needles, a sharp drop in force was observed at moment of 
insertion, for all the tests. Furthermore, all graphs contained only one instant of force 
drop, as is expected. Figure 31 shows the result of one of the insertion force tests using 
‘less sharp’ microneedles. 
Figure 32 depicts a typical graph of insertion force measurement using partially 
‘sharp’ needles, while Figure 33 depicts one of the results obtained from ‘very sharp’ 
needles. The results from these tests were tabulated as shown in Table 3. 
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Table 2: Microneedles tip sizes used for skin insertion tests 
Needle type Tip area (!m2) SEM Image 
Blunt 18636.43 
 
Less Sharp 11083.57 
 
Sharp 3068.04 
 
Very Sharp 185.98 
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 The load cell used for this testing was rated at 500gf. For the blunt microneedle 
tests, the insertion into skin was not seen within 150% of this range. Since it is not 
advisable to use the load cell beyond this range, needle insertion of the blunt needles 
could not be observed. 
 
 
 
Figure 31:  Incident force of ‘less sharp’ microneedles 
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Figure 32: Incident force of ‘sharp’ needles 
 
 
Figure 33: Insertion force of ‘very sharp’ needles 
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Table 3: Force of insertion for different microneedle array tips 
Force of Insertion (gf) 
Test no. 
Blunt Needles Less Sharp Needles Sharp Needles 
Very Sharp 
Needles 
1 Not observed 442.4 228.3 11.5 
2 Not observed 478.78 199.8 11.3 
3 Not observed 504.23 179.27 10.1 
Average N/A 475.14 202.46 10.97 
  
The results of skin insertion tests, as seen from Table 3, clearly reveal a marked 
decrease of insertion force with sharpening of microneedle tips. In order to ascertain the 
dependence of tip area on insertion force, tip surface area of the three types of needles 
was calculated after a visual inspection of the needle tips. 
The tip area for the various microneedles was plotted versus the observed 
insertion force. Figure 34 depicts the dependence of needle insertion force on 
microneedle tip area. This dependence is seen to have the linear progression. 
Microneedles penetrate through the skin at the critical puncture pressure. Since the 
applied pressure is a function of applied force and tip area, the linearity seen in Figure 
34 is expected, and, in fact corroborates the validity of the results. From the slope of the 
graph, the average penetration pressure per needle was found to be 0.0395 gf/!m2. 
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Figure 34:  Dependence of insertion force on microneedle tip area 
 
5.4.1 Analysis of Results From Variation of Tip Geometry  
It is observed that when insertion force is high, the needles penetrate almost 
instantly. This is seen as a vertical drop in force at instant of insertion in Figure 30. 
However, as the insertion force reduces, the force drop becomes more gradual, as seen 
in Figure 32. The force drop is most gradual when the insertion force is lowest, as in the 
case of ‘very sharp’ needles, and is seen in Figure 33. This shows that after the stratum 
corneum ruptures, the needles penetrate smoothly and relatively slowly into the lower 
epidermis when the penetration force is low.  This is as opposed to a much faster, 
almost instant penetration when the insertion force is high.  
It should also be mentioned that all needles might not be penetrating at the same 
instant. Although care was taken to align the needles along a plane parallel to the skin 
surface, there might be slight staggering of the needle tips. Thus, at soon as one needle 
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enters, the other would follow close behind; a mechanism that might only be quantified 
with equipment of higher resolution. 
5.4.2 Calculation of Skin Toughness 
 It has been postulated that when the energy delivered to the skin exceeds the 
energy needed to create a tear in the skin, the needle inserts into skin [94]. A similar 
approach was used by Pereira et. al. [144] to model tears into skin initiated and 
propagated with scissors.  
 The work input, is related to the change in potential energy between unaltered 
skin and the skin just prior to needle penetration.  
Therefore, $W="F dx, where F is the force applied by the needle, x is the axial position of 
the needle, and the boundaries of integration are from the point of needle contact with 
the skin to the point of needle insertion. 
The fracture toughness of the skin (Gp) depends on the interface area between the 
needles and the skin, and the total work input. 
Therefore, , 
where Gp is the puncture fracture toughness and xi is the displacement where insertion 
occurs. The left-had side of the equation, i.e. the potential energy, was calculated as the 
area under the load versus displacement curve before penetration. 
From the area under the curve for the ‘less sharp’, ‘sharp’ and ‘very sharp’ needles, the 
fracture toughness of skin was calculated. The units were converted to the standard skin 
toughness unit kJ/N2. The results are shown in Table 4. 
 
 
Fdx
x= 0
x= xi
" =GpA
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Table 4: Skin toughness measured via each microneedle 
Type of 
needle 
tip 
Area under 
curve before 
point of 
penetration (gf 
!m) 
Microneedle 
tip area 
Skin 
toughness 
(kJ/m2) 
Very 
Sharp 
489.5809 185.98 26.32 
Sharp 8087.01 3068.04 26.35 
Less 
Sharp 
22351.18 11083.57 20.16 
 
 The value of skin toughness measured from these experiments are very close to 
the value of 30.1 kJ/m2 reported by Davis et. al. and even closer to the value of 26.9 
kJ/m2 reported by Purslow et. al. [145]. 
 
5.5 Microneedle Fracture Strength Testing  
 It is imperative to know the fracture strength of microneedles in order to ascertain 
their physical limits. However, analytical analysis of beams does not translate to the 
micro-scale, and thus strength assumptions cannot be made. Needle failure due to axial 
loads may be due to heterogeneous peak stresses within the bulk material. Usually 
these peak stresses are the cause of needle failure, and fracture or buckling equations 
based on homogeneity of the material consistently over-estimate the strength of needles 
[94].  
 In order to test the microneedle strength, 200 micron tall needles were mounted 
onto a rigid aluminum block whose movement could be controlled via micromotor 
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actuators. A 0.5 mm wide stainless steel post was attached to another aluminum block, 
which was in turn mounted on the load cell. 
 By visual monitoring, the steel post was aligned axially along individual  
microneedles, one at a time. The microneedle being tested was pressed against the 
steel post at a rate of 50 microns/minute. Force and distance data was recorded along 
with a video of the needle collapse. 
 
 
 
 Figure 35:  Schematic of axial fracture test setup 
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Figure 36:  Microneedle aligned with steel post for axial testing. Inset: Microneedle 
completely collapses with no stub remaining 
 
 Axial fracture testing was done on 36 gauge hollow silicon microneedles. The 
microneedle is seen to collapse completely at its critical load. There was no bending of 
the needle observed. Also needles collapse completely from the base, with no stub 
remaining. Figure 36 shows a microneedle aligned axially with the steel post. Figure 37 
shows the fracture force obtained, which is the peak incident force. The graph has slight 
non-linearity seen during rise in the incident force. This is probably due to slight 
inadvertent slippage of the needle over the steel post, or due to minimal buckling of the 
needle itself. Due to low precision of the visual monitoring setup, it is not possible to 
resolve any slippage or buckling of the needle. However, the setup is adequately 
suitable to ascertain the peak incident force, which is the parameter of interest. 
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Figure 37: Axial fracture test on 36 gauge microneedle 
 
Table 5 shows the results of the axial fracture tests. The axial strength of the 
smallest fabricated needles was at the upper range of the load cell failure rating. The 35 
gauge needles were also tried, but did not fracture within the load cell usage limit. 
Strength testing on the 33 and 34 gauge needles was not attempted since their strength 
rating was expected to be much higher. 
 
Table 5: Axial fracture strength of silicon needles 
 Axial Fracture Strength (gf) 
Test no. 36-gauge needle 35 gauge needle 33 and 34 gauge 
1 661.85 Out of range 
2 874.47 Out of range 
3 682.49 Out of range 
Test not performed 
Mean 739.6 N/A N/A 
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5.6 Shear Fracture Testing 
 The shear fracture strength of microneedles has not been reported. Microneedle 
usage involves stresses related to the non-uniformity of skin contour, inadvertent 
slippage during insertion or removal, and reasonable human movements during period 
of penetration. These cause lateral forces to be applied on the needles. Breakage due to 
shear is a common cause of needle failure. In these tests, shear strength of needles was 
measured by aligning the needles perpendicular to the steel post used in the axial load 
testing. The steel post was pushed against the microneedle tips at the speed of 50 
microns/minute. Care was taken to align the post as high as possible for successful 
needle breakage. This is because the measured shear force increases if the point of 
lateral force is lowered. Tests were done on multiple needles within each array, till 
reliable results were obtained. All the test needles were 200 micron long with a blunt tip 
and varied only in their gauge sizes.  The experiments were captured on video. 
 
 
Figure 38: Schematic of shear fracture test setup 
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Figure 39: Steel post aligned perpendicular to silicon microneedle for shear strength 
testing 
 
 
 
Figure 40: Shear fracture test on 33 gauge microneedle 
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Graphs were plotted for each of the shear tests. Figure 40 shows a typical plot of 
shear fracture tests. The point of force drop represents the instant when the needle 
breaks. The results of shear testing are shown in Table 6. 
 
Table 6: Axial fracture strength of silicon needles 
 Shear Fracture Strength (gf) 
Test no. 
33 gauge 
needle 
34 gauge 
needle 
35 gauge 
needle 
36 gauge 
needle 
1 262.18 186.9 84.98 36.77 
2 255.44 199.68 84.59 38.29 
3 308.05 170.42 70.14 31.77 
Mean 275.22 185.67 79.9 35.6 
 
The variation of shear force for different needle dimensions is shown in Figure 
41.  
 
Figure 41: Shear force variation for various needle dimensions 
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CHAPTER 6 
SILICON DIOXIDE MICRONEEDLES 
 
Silicon Dioxide needles were fabricated in order to explore their use for drug 
delivery or extraction of biofluids. Two types of microneedle lumen shapes were 
investigated – circular and square. Both types of microneedles were fabricated to have 
0.8 to 1 micron sidewall thickness and 100 to 120 micron height. The circular 
microneedles had 50 micron diameter, while square microneedles had 50 micron edge 
length. 
Traditional fabrication methodologies employ lapping of bulk silicon, which 
dramatically reduce the obtainable length of microneedles. Also, lapping is a harsh 
process, and usually results in an uneven or sloping surface. This research involved 
fabrication of silicon dioxide microneedles using silicon nitride as an etch–stop layer for 
DRIE. The same nitride layer acts as an oxide barrier. This novel use of silicon nitride 
results in no loss of the bulk silicon.  
 
6.1 Fabrication of Silicon Dioxide Microneedles 
 Fabrication of silicon dioxide microneedles was done using 400 micron silicon 
wafer. The process starts with deposition of PECVD silicon dioxide on top and PECVD 
silicon nitride on bottom. Patterning of top oxide layer is done to form holes. This is 
followed by DRIE etching of silicon. The bottom nitride layer acts as a DRIE etch-stop. 
Thermal oxidation of silicon wafer is done to form microneedle sidewalls. The bottom 
nitride layer acts as an oxidation barrier for the bottom side of the wafer. Wet etching of 
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bottom nitride using phosphoric acid (has high selectivity to oxide). Finally wet etching of 
silicon using TMAH is done to form out of plane silicon dioxide microneedles. Figure 42 
depicts the fabrication process of silicon dioxide microneedles. 
  
 
 
Figure 42: Fabrication process of Silicon Dioxide Microneedle 
 
In this process it is critical for the silicon nitride to maintain integrity, otherwise a 
backside Helium leak occurs during DRIE, ceasing the process.  During fabrication 
various nitride thickness were tried to achieve the desired result. Figure 43 shows a 
silicon nitride membrane holding up a silicon alignment marker.  
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Figure 43: Silicon nitride membrane holding up a silicon alignment marker 
 
 
 
Figure 44: Ashing of photoresist over alignment markers 
 
Due to loading effects in DRIE Bosch process larger areas get etched faster than 
the smaller holes. This caused the alignment windows to get etched through before the 
holes. Since this process does not require alignment, and the alignment markers in the 
alignment windows were superfluous, these areas were covered up by photoresist. 
However due to thermal effect the resist gets ashed. Finally, a polyimide tape was used 
to cover these areas. This tape is compatible with DRIE plasma processing, and holds 
up reliably during the dry etch.  
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Figure 45: Ashing of photoresist over alignment markers 
 
6.1.1 Flaring of Microneedle Tips 
 It was found that the fabricated microneedles flared at the tips. This result is due 
to the ‘notching effect’ in DRIE. This is a well established undesirable effect in some 
DRIE machine. When a dielectric etch-stop region is reached during DRIE, charge 
accumulation takes place locally. This causes the impinging ions to deflect sideways. 
Thus notching in the end region takes place. This effect has been widely studied, and 
many modern machines employ special processes that do not result in this effect. The 
machine used for this fabrication (Alcatel AMS 100 SDE) does not include the 
company’s ‘HRM’ capability that removes this effect.  
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Figure 46: Flaring at the tip of silicon dioxide microneedle 
 
In order to remove the flare, a slight CMP step was employed prior to TMAH 
based silicon etching. The wafer was etched back to approximately 2-3 micron. After, 
CMP it was observed that the flares were removed as required. 
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Figure 47: Circular silicon dioxide microneedle 
 
 
Figure 48: Array of silicon dioxide microneedles 
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Figure 49: Square silicon dioxide microneedle 
 
6.2 Skin Penetration Testing of Microneedles Into Human Skin 
 Penetration force testing of microneedles was done on cadaver skin. The setup 
was same as that used for silicon needle insertion tests. For the oxide needles, a 15 x15 
array of the needles was used. No clear drop in force was seen as that observed in 
silicon needles. This is because the needle tip area for oxide needles is extremely small. 
Thus the penetration is expected to happen with just a few gram-force. Due to 
irregularities of the skin surface, the plot of force obtained is a bit noisy at the low end. 
Even though a few instances can be interpreted as needle insertion, distinguishing them 
from noise cannot be certain. Thus the insertion force could not be tabulated.  
 Visual inspection of the needles through a camera showed that the needles were 
clearly intact during insertion. Multiple insertion and retrieval did not result in breakage of 
the needles. Faint images of the needles are seen through the microscope are circled in 
Figure 50. 
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Figure 50: Insertion of oxide microneedles into skin.  
  
 
Figure 51: Skin penetration force of oxide needles 
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Since, no reliable force date was obtained, in order to verify successful insertion; 
as opposed to mere indentation), the needles were manually inserted into human 
cadaver skin. Green tattoo dye was smeared at the back end of the needle arrays. The 
dye gets transported through the needles via capillary forces. Histology of the skin 
samples was performed to observe for breakages in the Stratum corneum. The skin was 
fixed in 10% neutral buffered formalin, processed (standard processing) and embedded 
in paraffin for sectioning and hematoxylin and eosin (H&E) staining. Figure 50 depicts 
successful penetration of the needles. Green tattoo dye indicates successful penetration 
of needles through the stratum corneum and part of epidermis. 
To depict penetration of the entire array of needles, Photomicrographs were 
taken of the length of the skin section (overlapping sections), and were merged using 
PhotoShop Elements 6 (photomerge option) to piece together the entire length of skin. 
 
 
 
Figure 52: Post penetration histology on human skin 
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6.3 Fracture Strength Testing 
 Axial force testing was done using a similar setup for silicon needles. It was 
observed that as opposed to silicon needles, the oxide needles did not collapse 
instantly. Rather, in many cases, the needle broke a small part at a time, and in effect 
was ground slowly to its base. This effect can be observed as multiple spikes in the axial 
fracture force data. 
 
 
Figure 53: Axial fracture testing of oxide needles 
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Figure 54: Axial fracture strength of circular needles 
 
Figure 55: Axial fracture strength of square needles 
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 The axial fracture force of circular needles was found to be slightly higher than 
the square ones. This is similar to critical loading on circular versus square hollow 
metallic beams. There too, the circular beams buckle later than the square ones. 
However, the equations for buckling cannot be translated to microneedles as needles 
failure is due to fracture because of peak stresses, rather than buckling. 
 
Table 7: Axial fracture strength of silicon dioxide needles 
 Axial Fracture Strength (gf) 
Test no. 
Circular 
needles 
Square 
needles 
1 2.5 2.17 
2 3.86 2.08 
3 3.1 2.00 
Mean 3.15 2.08 
 
6.4 Shear Fracture Testing 
 Shear fracture of oxide microneedles was tested. The needles are so small as 
compared to their silicon counterparts, all force data was seen as spikes rather than a 
gradual rise in force. In one test it was possible to break multiple needles in a single 
motion of the steel rod. In that case, spikes could be observed at the interval of 1000 
microns, which corresponded to the array pitch. 
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Figure 56: Shear fracture strength of oxide needles 
 
Table 8: Shear fracture strength of silicon dioxide needles 
Shear Fracture Strength (gf) 
Test no. 
Circular 
needles 
Square 
needles 
1 2.14 0.5 
2 2.25 0.6 
3 2.05 0.9 
4 2.40 0.6 
Mean 2.21 0.65 
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Figure 57: Shear fracture strength of circular needles 
 
 
Figure 58: Shear fracture strength of square needles 
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It was observed that even though square needles had only slightly lower axial 
fracture strength, their shear fracture strength was a order of magnitude lower. 
6.4.1 Analysis of Silicon Dioxide Needle Fracture Results 
 The results of the axial fracture tests on the oxide needles show that the square 
needles fracture much more easily as compared to the circular needles. This result is 
expected as even in the ‘macro’ domain, the critical loading limits of circular posts is 
much higher than those of square posts. However, the fabricated structures cannot be 
assumed to be simple vertical hollow posts with uniform sidewall thicknesses.  
Retardation of oxidation at sharp corners plays a very important role. Oxidation does not 
take place uniformly in 2-D structures. The thickness of oxide obtained is much lower 
around sharp corners, and the effect is even more pronounced in the case of concave 
corners [146]; as are present in our fabrication process. 
 
 
Figure 59: Oxidation retardation in square microneedles 
 
Figure 59 shows a sketch of the oxidation retardation effect, in the case of 
square microneedles. Due to this effect, the structural integrity of a square microneedle 
is even lower than what can be expected from a needle having homogeneous sidewall 
thickness. The much lower shear fracture strength of oxide microneedles can be 
attributed to this effect.
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CHAPTER 7 
FUTURE WORK AND CONCLUSION 
 
7.1 Future Work 
7.1.1 Extraction of Interstitial Fluid From Human Cadaver Skin 
Research needs to be done to fill the gap in scientific literature regarding 
interstitial fluid withdrawal using microneedle arrays. Microneedle arrays need to be 
packaged and used in conjunction with a pump to extract biofluids from skin. The setup 
can employ a Franz cell with cadaver skin as a membrane. Any colored liquid of low 
viscosity may be used for initial tests. 
 
Figure 60: Packaged microneedles for fluid extraction 
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The needle array will have to be bonded to a glass microfluidic chamber at the 
back end. The chamber would in turn be connected via PEEK microfluidic tubing to a 
syringe pump. Interstitial fluid may be withdrawn from human skin using the syringe 
pump and flow rates can be determined. A study can analyze the effect of microneedle 
shape, microneedle diameter, array size and array pitch on the flow rates.  
7.1.2 Optimization of DRIE Etching to Increase Oxide Needle Strength 
DRIE process is essentially an accrual of a small isotropic etch in every Bosch 
cycle resulting in an overall anisotropic etch. The isotropic etches result in sidewall 
roughness, also known as scalloping effect. Figure 61 shows the SEM of a DRIE trench 
clearly showing the scalloping of sidewalls.  This feature, in effect, provides fracture 
points for microneedles. By reducing the sidewall roughness, microneedle robustness 
can be greatly increased. The research task can focus on changing the Bosch recipe in 
the DRIE process to achieve greater sidewall smoothness. 
 
 
  
Figure 61: DRIE trench depicting scalloping effect 
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7.2 Conclusion 
In this research, the geometry of silicon microneedles has been varied via DRIE 
processing to yield sharpened tips. Sharpening of microneedle tips provides reduced 
skin insertion force without compromising structural strength. Variation of skin insertion 
force of microneedles with change in tip sharpness has been studied, and toughness of 
human skin derived to be approximately 26 kJ/m2. The axial and shear fracture limits of 
the microneedles have also been studied. Axial fracture of 36 gauge silicon needles 
takes place at an average force of 740gf. Shear fracture force of silicon needles varies 
from 275gf (33 gauge needles) to 35.6gf (36 gauge needles). Fracture limits of circular 
and square shaped silicon dioxide needles show reduced strength of square needles; 
which is pronounced in the case of shear fracture.  
Skin interaction systems containing bio-engineered interfaces will revolutionize 
the biomedical industry in the coming decades. They promise exceptional capabilities in 
diverse transdermal diagnostic and therapeutic applications. Next generation therapeutic 
methods using advances in genomics, proteomics, pharmacogenomics etc., will all 
benefit from to the capabilities provided by these micro-components. Development of 
customized instrumentation will enable real-time electrical, mechanical and 
electrochemical measurements on the skin surface and also provide novel methods of 
drug delivery. Micromachined needles form the technological foundation for bio-
engineered skin interfaces. These enabling components will be a common denominator 
in design of human interface lab-on-a-chip systems.  
It is evident that microfluidic approaches to diagnosis and therapeutics offer 
multifaceted advantages over their conventional counterparts. However, successful 
clinical implementation of such systems would entail overcoming numerous challenges 
in areas of design, fabrication, electronics integration, deployment, testing, and data 
interpretation among many others. The interdependencies between the various design 
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variables and the obtained characteristics are highly complex, and warrant 
multidisciplinary research initiatives. Optimum utilization of this technology depends 
upon our capacity to identify and resolve, qualitatively and quantitatively, the various 
parametric entities involved.  
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APPENDICES 
114 
Appendix A: Microneedle Gauge Sizes 
 
33 gauge: Inner Diameter - 100 micron; Outer Diameter 200 micron 
34 gauge: Inner Diameter - 85 micron; Outer Diameter 160 micron 
35 gauge: Inner Diameter - 65 micron; Outer Diameter 130 micron 
36 gauge: Inner Diameter - 30 micron; Outer Diameter 100 micron 
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Appendix B: Photolithography Recipe for AZ4620 
 
Step 1: Spin HMDS at 3500 rpm for 30 seconds. 
Step 2: Spin photoresist AZ4620 at 500 rpm for 10 seconds followed by 2500 rpm for 60 
seconds. 
Step 3: Soft bake in oven at 90°C for 20 minutes. 
Step 4: Leave wafer at ambient temperature for 1 hour to rehydrate resist.  
Step 5: Expose in Karl-Suss aligner for 55 seconds at 25 mW/cm2 intensity. 
Step 6: Develop in 1:1 AZ400K:H2O for 4 minutes. 
Step 7: Hard bake in oven at 90°C for 20 minutes. 
Result: Photoresist thickness obtained is approximately 6.6 to 7 micron. 
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Appendix C: Silicon DRIE Recipe 
 
Etch step gases    SF6 and 300 sccm with 3 second cycle. 
Passivation step gases  C4F8 at 200 sccm with 1.4 second cycle, and O2 at  
20 sccm with 1.4 seconds cycle 
Pressure:     5.25 x 10-1 mTorr 
Source generator power:   2400 W 
Substrate holder power:   Used in pulsed mode 
High cycle at 100 W for 25 millisecond 
Low cycle at 0 W for 75 millisecond 
Substrate holder He pressure:  9.75 x 10-3 mTorr 
Bias Voltage:     -185 V (negative) 
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